Editors for Medicine
Senior editors
-
Ricardo Azziz
University at Albany, SUNY, United States
University of Alabama at Birmingham, United StatesRicardo Azziz, MD, MPH, MBA is an educator-scientist-executive with over 25 years of leadership experience in higher education, research, and academic health, who serves as Chief Science & Strategy Officer, and EVP for Operations, Strategy, and Scientific Affairs at The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center. He served as Chief Officer of Academic Health & Hospital Affairs of the State University of New York (SUNY) System Administration, as founding President of Georgia Regents University (now Augusta University), as founding CEO of the Georgia Regents Health System (now Augusta University Health System), and as president of the Georgia Health Sciences University. He also served as Deputy Director of the Clinical & Translational Sciences Institute and as Assistant Dean for Clinical and Translational Sciences at UCLA, as Director of the Center for Androgen-Related Disorders at Cedars-Sinai Medical Center in Los Angeles, and as founder and Executive Director/Senior Executive Director of the Androgen Excess & PCOS Society.
Among other national and international advisory capacities, he has served on multiple NIH committees, chaired the U.S. FDA Advisory Board on Reproductive Health Drugs, and served on the oversight committee for the California Institute for Regenerative Medicine. He has received, among other recognitions, the 2000 President's Achievement Award of the Society for Gynecologic Investigation; elected member of the Association of American Physicians; and is recipient of the 2014 Alumni Fellow Award of the Pennsylvania State University Alumni Association.
He serves on the faculties of the School of Public Health, University at Albany, SUNY and the Schools of Medicine and Public Health, University of Alabama at Birmingham.
- Expertise
- Medicine
- Research focus
- reproductive health
- reproductive biology
- reproductive endocrinology
- gynecology
- ob-gyn
- women's health
- polycystic ovary syndrome (PCOS)
- hirsutism
- androgen excess
- adrenal hyperplasia
- health policy
- public health
- social determinants of health
- healthcare organization
- Experimental organism
- human
- Competing interests statement
- Ricardo Azziz is a consultant for Spruce Biosciences and Fortress Biotech, and holds stocks at Martin Imaging.
-
Matthias Barton
University of Zurich, Switzerland
Matthias Barton, MD, is a Professor of Cardiology at the University of Zurich. His clinical and investigative focus are general cardiology and preventive medicine, with a particular interest in coronary artery disease and myocardial infarction. His work explores mechanisms of atherosclerosis, heart disease in women, and vascular factors contributing to cardiovascular health and disease.
- Expertise
- Medicine
- Research focus
- cardiovascular medicine
- coronary artery disease
- vascular biology
- heart disease in women
- molecular medicine
- Competing interests statement
- Matthias Barton has received funding from the Swiss National Science Foundation and is on the editorial boards of the American Journal of Cardiovascular Disease, the American Journal of Physiology Regulatory Integrative & Comparative Physiology, Endocrine and Metabolic Science, Experimental Biology and Medicine, Arteriosclerosis, Thrombosis and Vascular Biology and Hypertension, official journals of the American Heart Association. He has been an elected ordinary member of the Academy of Europe (Academia Europaea) since 2017.
-
Balram Bhargava
Indian Council of Medical Research, India
Dr Bhargava is the Director General of the Indian Council of Medical Research (ICMR) Secretary, Department of Health Research, (Ministry of Health & Family Welfare), Government of India.
Professor (Dr) Balram Bhargava was born in Lucknow 21st July 1961. He received all his medical training at the King George Medical College, Lucknow. Further, he received advanced training at the Gardiner Institute, University of Glasgow and the Washington Heart Centre, Washington DC.
Balram Bhargava is Professor of Cardiology at the All India Institute of Medical Sciences, New Delhi, and also serves as the Executive Director for Stanford India Biodesign Centre, School of International Biodesign (SiB).
He is a cardiologist at the forefront of biomedical innovation, public health, medical education, and medical research. He directs the School of International Biodesign at AIIMS, an interdisciplinary programme to foster innovation and design of low-cost implants and devices which has led to more than thirty patents on low-cost medical devices and a dozen start-ups. He developed the indigenous Platinum Iridium coil coronary stent and has been instrumental in clinically evaluating and establishing medicated Indian stents. He has led innovations initiatives, such as Society for Less Investigative Medicine (SLIM). He is currently providing leadership for creative disease prevention, early detection, and transport system for sick cardiac patients (mission DELHI (Delhi Emergency Life Heart-Attack Initiative) by trained motorcycle first responder Paramedics).
Professor Bhargava was awarded the Padma Shri by the Indian government for his contributions to medicine. He is also been awarded the SN Bose Centenary Award by the Indian National Science Congress, the National Academy of Sciences Platinum Jubilee Award, the Tata Innovation Fellowship, Vasvik Award for Biomedical Technology Innovation, the Ranbaxy Award, OP Bhasin Award in the field of Health and Medical Sciences and more recently the UNESCO Equatorial Guinea Prize for Life Sciences. Dr Lee Jong-Wook Memorial Prize for Public Health, 2019 by WHO Hqrs, Geneva and received President’s Medal Award from Royal College of Physicians and Surgeons of Glasgow, UK for his research in ‘Frugal Innovations’ in February 2020.
- Expertise
- Medicine
- Epidemiology and Global Health
- Research focus
- interventional cardiology
- stents
- restenosis
- coronary artery disease
- risk factors of valvular heart disease
- interventions of rheumatic heart disease
- epidemiology
- non-communicable disease
- infectious disease
- health policy
- public health
- Experimental organism
- human
- Competing interests statement
- Dr Bhargava is the founding editor of the British Medical Journal Innovations (BMJi) until 2018, and he is currently the Editor-in-Chief of the Indian Journal of Medical Research.
-
Christian Büchel
University Medical Center Hamburg-Eppendorf, Germany
Christian Büchel is a member of the Hamburg Center for Neuroscience in Hamburg, where he is also the Director of the Department for Systems Neuroscience at Hamburg University Medical Center. He holds an Affiliate Professor appointment in the Psychology department at the University of Hamburg. After Medical School at the University of Heidelberg, he performed postdoctoral research with Karl Friston as a Wellcome Research Fellow at the Wellcome Department of Imaging Neuroscience at UCL in London with a focus on effective connectivity.
Establishing his lab in Hamburg, he focused on the cognitive neuroscience of pain and motivation and initially studied decision making with an emphasis on delay discounting. In a parallel stream of projects he observed that the pain modulation underlying placebo analgesia can already be observed at the spinal cord level, a finding which he later also established for nocebo hyperalgesia. He is part of the IMAGEN study and during his time at Stanford he identified hypoactivation of reward circuits as a potential risk factor for addiction.
He is a member of the Academy of Science in Hamburg and was awarded the Jung Award for Medicine, the Gottfried Wilhelm Leibniz-Preis by the German Research Foundation, and the Wiley Young Investigator Award of the Organization for Human Brain Mapping for recognition of his work in cognitive neuroscience.
- Expertise
- Neuroscience
- Medicine
- Research focus
- cognitive neuroscience
- pain modulation
- decision-making
- fear
- anxiety
- addiction
- Experimental organism
- human
- Competing interests statement
- Christian Büchel has received research grants from the European Research Council, Deutsche Forschungsgemeinschaft and Bundesministerium für Bildung und Forschung. He serves on the board of reviewing editors of Science magazine. He serves on the Swiss National Research Council, the Scientific Advisory Board of the ICM in Paris and the Center for Behavioral Brain Sciences, Magdeburg, Germany.
-
Nancy Carrasco
Vanderbilt University School of Medicine, United States
Nancy Carrasco is the Joe C. Davis Professor and Chair of the Department of Molecular Physiology and Biophysics at the Vanderbilt University School of Medicine. She obtained her MD and Master’s in Biochemistry from the National Autonomous University of Mexico in her native Mexico City. Dr Carrasco did her postdoctoral work at the Roche Institute of Molecular Biology in New Jersey, for which she received a Fogarty International Fellowship. She then joined the Department of Molecular Pharmacology at the Albert Einstein College of Medicine, and later the Department of Cellular and Molecular Physiology at the Yale School of Medicine. Dr Carrasco has a longstanding interest in transport across biological membranes and in the role of membrane proteins in physiology and pathophysiology. Her cloning of the sodium/iodide symporter (NIS) has had numerous ramifications for many other fields, including structure/function of transport proteins, molecular endocrinology, gene transfer studies, cancer, and public health (she has served on the EPA’s Science Advisory Board). She has received numerous awards, including the Pew Award; the Arnold and Mabel Beckman Foundation Award; the Maria Sibylla Merian Award (Germany); the Merck Prize from the European Thyroid Association (Poland); the Rose Pitt-Rivers Lectureship at the British Endocrine Society Meeting (Scotland); the Noun Shavit Award (Israel); the Marshall S. Horwitz Faculty Prize for Research Excellence; and the Light of Life Award. She has served as president of the Society of Latin American Biophysicists. Dr Carrasco was elected to the National Academy of Sciences in 2015 and to the National Academy of Medicine in 2020.
- Expertise
- Medicine
- Biochemistry and Chemical Biology
- Structural Biology and Molecular Biophysics
- Research focus
- molecular endocrinology
- biochemistry of membrane proteins
- biophysics of membrane proteins
- mechanistic information of NIS
- regulation of NIS
- sodium/iodide symporter
- cross-talk between hormones
- metabolism
- Experimental organism
- mouse
- human
- Competing interests statement
- Dr Carrasco’s research has been funded by NIH. She is on the NICHD Board of Scientific Counselors.
-
Arturo Casadevall
Johns Hopkins Bloomberg School of Public Health, United States
Arturo Casadevall, MD, PhD is a Bloomberg Distinguished Professor and Chair of the W Harry Feinstone Department of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health. He obtained his BA in Chemistry at Queens College of the City University of New York. Previously, he served as Director of the Division of Infectious Diseases at Montefiore Medical Center, the University Hospital and Academic Medical Center for Einstein, from 2000–2006 and as Chair of the Department of Microbiology and Immunology from 2006–2014.
Dr Casadevall received both his MD and PhD (biochemistry) degrees from New York University. Subsequently, he completed his internship and residency in internal medicine at Bellevue Hospital in New York. He then completed subspecialty training in infectious diseases at Montefiore and Einstein. The author of over 700 scientific papers, numerous books and book chapters, Dr Casadevall’s major research interests are in fungal pathogenesis and the mechanisms of antibody action. In the area of biodefense, he has an active research program to understand the mechanisms of antibody–mediated neutralization of Bacillus anthracis toxins.
In recent years, Dr Casadevall has become interested in problems with the scientific enterprise and with his collaborators shown that misconduct accounts for the majority of retracted publications. He has suggested a variety of reforms to the way science is done. Dr Casadevall is the editor–in–chief of mBio, the first open access general journal of the American Society of Microbiology, and is on the editorial board of several journals including the Journal of Infectious Diseases and the Cell Surface.
He has also served in numerous NIH committees including those that drafted the NIAID Strategic Plan and the Blue Ribbon Panel on Biodefense Research. He served on the National Academy of Sciences panel that reviewed the science on the FBI investigation of the anthrax terror attacks of 2001 and has served on the NAS Committee of Federal Regulations and Reporting requirements. He has also served as a member of the National Science Advisory Board for Biosecurity from 2005–2014. In 2008, he was recognized by the American Society of Microbiology with the William Hinton Award for mentoring scientists from underrepresented groups. In 2015, Dr Casadevall was appointed a Commissioner to the National Commission on Forensic Science, the United States Department of Justice. He has served as President of the Medical Mycology Society of America, Chair of American Society for Microbiology Division F, Chair of the American Society for Microbiology Career Development Committee, Co–Chair of the National Institute of Allergy and Infectious Diseases Board of Scientific Counselors, and currently serves on the Scientific Council/Advisory Board for the Pasteur Institut and VIB Research Institute in Belgium. He is a member of the American Society for Clinical Investigation, American College of Physicians and the Association of American Physicians, and was elected Fellow of the American Association for the Advancement of Science and the American Academy of Microbiology. In 2014, he became an elected member of the National Academy of Medicine and in 2017, he was elected to the American Academy of Arts and Sciences.
- Expertise
- Immunology and Inflammation
- Medicine
- Microbiology and Infectious Disease
- Research focus
- molecular microbiology and immunology
- pathogenic microbes
- cryptococcosis
- anthrax
- mycobacterium tuberculosis
- vaccines
- Experimental organism
- Cryptococcus neoformans
- Bacillus anthracis
- Competing interests statement
- Arturo Casadevall is Editor in Chief of mBio (until 2025), and serves on the editorial boards of Journal of Experimental Medicine, Journal of Clinical Investigation, and Journal of Infectious Diseases.
-
Murim Choi
Seoul National University College of Medicine, South Korea
Murim Choi’s main scientific question is to elucidate the genetic mechanisms of human diseases. To address this, his expertise lies in the functional interpretation of human genetic variants using genomic and bioinformatic methodologies. He graduated from Seoul National University (SNU), Seoul, Korea, majoring in Molecular Biology (BS and MS). During the Ph.D course at Duke University, he studied cardiovascular system development in mice. In his postdoctoral training at Yale University, he studied human genetics, setting up a whole exome sequencing pipeline and applying it to various human diseases to identify causal genes. He received a K99/R00 grant for the postdoctoral works and was a recipient of SNU Invitation Program for Distinguished Scholar grant.
Establishing his independent lab at SNU, he has been studying the genetic mechanisms of rare disease pathogenesis, focusing on cases with neurodevelopmental defects. His current approach combines developmental biology and genetics, shaped by the fact that most pediatric rare disease patients experience congenital problems. More recently, his group has undertaken common disease research. His group recently established a bioinformatic pipeline that allows screening of eQTL signals only functioning in the non-alcoholic fatty liver disease (NAFLD) status and validated its utility. At SNU, he has been instrumental in establishing genetics and genomics methodologies by collaborating with clinicians in SNU Hospital. His lab has recently established protocols in advanced functional genomics approaches, including single-cell sequencing, saturation mutagenesis, modifier screening, and cell tracing technique to understand the genetic mechanisms underlying disease progression.
He has a strong interest in clinical and translational research, especially in elucidating genotype-phenotype relationships that may lead to human diseases. In 2018, he was selected as a member of the Young Korean Academy of Science and Technology.
- Expertise
- Genetics and Genomics
- Medicine
- Research focus
- rare diseases
- neurodevelopmental disorders
- functional characterization of genetic variants
- bioinformatics
- Mendelian genetics
- Competing interests statement
- Current funding: Genetic elucidation of rare developmental disorders (200M KRW/year (~152,800 USD); Apr. 2014-Sep.2022; National Research Foundation of Ministry of Science and ICT); Genetic elucidation of gene expression noises (300M KRW/year (~229,200 USD); Mar. 2021-Feb. 2025; National Research Foundation of Ministry of Science and ICT); Discovery of NAFLD causing genes using single cell expression quantitative trait loci approach (80M KRW/year (~61,120 USD); Apr. 2021-Dec. 2025; National Research Foundation of Ministry of Science and ICT).Other editorial roles: editor of Experimental and Molecular Medicine (Springer Nature)
-
Miles P Davenport
University of New South Wales, Australia
Miles Davenport is Professor of Medicine and Head of the Infection Analytics Program at the Kirby Institute for Infection and Immunity at UNSW Sydney. He graduated in medicine from the University of Sydney and completed his DPhil at the University of Oxford in immunology before retraining in mathematical biology. He leads a team of applied mathematicians who use statistical analysis and modelling to understand host-pathogen interactions in infection and immunity. This involves collaboration with a wide variety of experimental and clinical scientists both in Australian and internationally. Major areas of investigation include understanding HIV latency, malaria immunity and treatment, and neonatal immune development. He is a past-President of the Australasian Society for Immunology and is supported by an NHMRC (Australia) Investigator grant.
- Expertise
- Immunology and Inflammation
- Microbiology and Infectious Disease
- Epidemiology and Global Health
- Medicine
- Research focus
- virology
- immunity
- vaccines
- HIV/AIDS
- mathematical modelling
- host-pathogen interactions
- biostatistics
- Competing interests statement
- Miles Davenport receives funding from the National Health and Medical Research Council (Australia), the Australian Research Council, and the National Institutes of Health (USA). He is an Associate Editor at PLoS Computational Biology and on the Editorial Board of Immunology and Cell Biology.
-
Betty Diamond
The Feinstein Institute for Medical Research, United States
Betty Diamond received an MD from Harvard Medical School. She performed a residency in Internal Medicine at Columbia Presbyterian Medical Center, and then a post-doctoral fellowship in Immunology with Dr Matthew Scharff at the Albert Einstein College of Medicine. She is currently Director of the Institute of Molecular Medicine at the Feinstein Institute for Medical Research.
Dr Diamond’s research has focused on the induction and pathogenicity of anti-DNA antibodies in Systemic Lupus Erythematosus. She showed that somatic mutation of immunoglobulin genes can generate autoantibodies in mice and humans, making the germinal center a focus in disease pathogenesis. Her laboratory has also demonstrated that a subset of anti-DNA antibodies cross-reacts with the NMDA receptor and showed that autoantibodies can cause aspects of neuropsychiatric lupus, creating a paradigm for antibody-mediated changes in brain function in many conditions. Most recently, she has developed a research program on the immunomodulatory functions of C1q.
She received the Outstanding Investigator Award of the ACR in 2001, the Lee Howley Award from the Arthritis Foundation in 2002, and the Recognition Award from the National Association of MD-PhD Programs in 2004 and the AAI Distinguished Fellow Award in 2019. In 2006, she was elected to the Institute of Medicine and became a fellow of the AAAS. She has served on the Scientific Council of NIAMS and the Board of Directors of the American College of Rheumatology. She is a past President of the American Association of Immunologists.
- Expertise
- Medicine
- Immunology and Inflammation
- Research focus
- B cells
- systemic lupus
- neuropsychiatric lupus
- autoantibodies
- autoimmunity
- Experimental organism
- human
- mouse
- Competing interests statement
- Betty Diamond receives funding from the NIH, LuCIN (Lupus Clinical Investigators Network), Lupus Research Alliance, DOD Lupus and Leidos Biomedical Research, Inc.. She is the Chief Editor at Molecular Medicine and a Deputy Editor for Frontiers in Immunology.
-
Wafik S El-Deiry
Brown University, United States
Wafik El-Deiry, MD, PhD, FACP is Associate Dean for Oncologic Sciences at the Warren Alpert Medical School, Director, Cancer Center at Brown University, and Director of the Joint Program in Cancer Biology at Brown and Lifespan. He is a Professor of Pathology and Laboratory Medicine, Professor of Medical Science, and Mencoff Family University Professor at Brown. He sees patients in his weekly clinic at Rhode Island Hospital focused on care of patients with colorectal cancer and participates in clinical trials based on his laboratory’s research on novel therapeutics. He previously served as Deputy Director for Translational Research, co-Leader of the Molecular Therapeutics Program, Professor of Oncology, and the William Wikoff Smith Endowed Chair in Cancer Research at Fox Chase Cancer Center. From 2010 through 2014 Dr El-Deiry was the Rose Dunlap Professor of Medicine and Chief of Hematology-Oncology at Penn State. In 2009, El-Deiry became an American Cancer Society Research Professor. He was previously a tenured Professor of Medicine (Hematology-Oncology), Genetics, and Pharmacology at University of Pennsylvania, co-Leader of the Radiobiology and Imaging Program at the Abramson Cancer Center and Associate Director for Physician-Scientist Training in Hematology-Oncology when he left Penn in 2010. He earned MD/PhD degrees from University of Miami School of Medicine and completed internal medicine residency and medical oncology fellowship at the Johns Hopkins Hospital and the Johns Hopkins Oncology Center. As a practicing academic Oncologist, his scientific interest and expertise is in cell death, drug resistance in cancer and drug discovery and development. El-Deiry founded two companies, Oncoceutics, Inc. and p53-Therapeutics, Inc.
El-Deiry discovered p21(WAF1) as a p53 target gene, universal cell cycle inhibitor, and tumor suppressor gene that for the first time explained the mammalian cell stress response. He discovered TRAIL receptor DR5 and its regulation by p53. TRAIL is part of the host immune system that suppresses cancer and its metastases. His lab created a knock-out mouse for TRAIL receptor DR5 and this mouse is tumor prone and develops an inflammatory syndrome in the lungs and gut after sub-lethal irradiation. He identified c-Myc as a major determinant of TRAIL sensitivity and demonstrated synergy between TRAIL therapy and multi-kinase inhibitor sorafenib. Building on his prior accomplishments, El-Deiry discovered ONC201/TIC10 as a first-in-class TRAIL pathway inducer that is orally bioavailable and crosses the blood-brain barrier to treat brain tumors. TRAIL and Foxo3a are required for the anti-tumor effect of ONC201 through dual blockade of ERK and Akt kinases that promotes the nuclear translocation of the Foxo3a transcription factor which directly regulates the TRAIL gene. Data from El-Deiry’s lab identified that ONC201 induces TRAIL receptor DR5 through an integrated stress response involving ATF4 and CHOP transcription factors. Patients with among the most aggressive gliomas (H3K27M mutant DIPG) have had exceptional responses to ONC201.
As a physician-scientist, Dr El-Deiry has worked to bring new discoveries to the clinic. He is committed in the next phase of his career to unraveling the mechanisms involved in p53 pathway restoration by candidate therapeutics his lab has discovered. This is exciting as he is defining a novel class of anti-cancer drugs with p53 pathway restoration and S-phase checkpoint targeting and recognizing ATF4 as a major transcription factor mechanism for p53 pathway restoration in p53-null or p53 mutant tumor cells. He is establishing transcriptomic and proteomic data sets with chemotherapy that acts through p53, and with novel small molecules that restore the p53 pathway in p53-deficient or mutant p53 expressing cells. He is exploiting medicinal chemistry and organoid technologies to perform his translational science that is leading to clinical trials some of which he leads. Dr El-Deiry conducts basic and translational clinical oncology therapeutics research through funded NIH grants, Foundations and industry. He is a member of the ASCI, AAP, Past President of the Interurban Clinical Club, previous Chair of ASCO’s Tumor Biology Track, and past Chair of an NIH Study Section on Cancer Therapeutics. Dr El-Deiry has trained many students and post-doctoral fellows, physician-scientists, and continues to mentor junior scientists and faculty in basic and translational cancer research.
- Expertise
- Medicine
- Cancer Biology
- Research focus
- cancer
- tumor suppressor genes
- colorectal cancer
- p53 pathway
- cell death
- medical oncology
- drug development
- drug discovery
- p21(WAF1)
- ONC201/TIC10
- physician-scientist issues
- Experimental organism
- human
- mouse
- Competing interests statement
- Dr El-Deiry receives funding from the NIH/NCI, the Warren Alpert Foundation, and D&D Pharmatech. He is a Specialty Chief Editor for the Cancer Molecular Targets and Therapeutics Section of Frontiers in Oncology. He is also a Section Editor for Molecular Oncology and HemOnc Today. Dr El-Deiry is the scientific founder and shareholder of Oncoceutics, Inc. and p53-Therapeutics, Inc.
-
Neil Ferguson
Imperial College London, United Kingdom
Neil Ferguson is Head of the Department of Infectious Disease Epidemiology at Imperial College London, where he leads the MRC Centre for Outbreak Analysis and Modelling. His research aims to improve the understanding of epidemiological factors and population processes that shape infectious disease spread in human and animal populations. A practical focus of his work is the analysis and optimisation of intervention strategies that are aimed at reducing transmission or disease burden.
- Expertise
- Epidemiology and Global Health
- Microbiology and Infectious Disease
- Medicine
- Research focus
- epidemiology and infectious disease
- emerging infections
- mosquito-borne infections
- statistical and mathematical tools
-
Eduardo Franco
McGill University, Canada
Eduardo Franco is Professor and Chairman, Department of Oncology, and Director, Division of Cancer Epidemiology, McGill University, Montreal. He holds BSc (1975) and Licentiate (1976) degrees in biology from Universidade de Campinas, Brazil, and master's (MPH) and doctoral (DrPH) degrees in public health microbiology from the University of North Carolina at Chapel Hill (1981-84). He was a Guest Researcher at the US Centers for Disease Control in Atlanta (1980-81 and 1983-84), and a post-doctoral fellow in cancer epidemiology during 1984 at the International Agency for Research on Cancer in Lyon, France, at the US National Cancer Institute (NCI) in Bethesda, and at Louisiana State University, in New Orleans. Since 1985, he has conducted epidemiologic research on the causes of cancer and on the means to prevent it or to improve patient survival. He is mostly known for his contributions to our understanding of human papillomavirus infection as the cause of cervical cancer and using this knowledge to prevent this cancer via vaccination and improved screening strategies. He received the Canadian Cancer Research Alliance’s Distinguished Service to Cancer Research Award, Lifetime Achievement Awards from the American Society for Colposcopy and Cervical Pathology and from the International Papillomavirus Society, the Women in US Government’s Leadership Award, the Canadian Cancer Society’s Warwick Prize, the Geoffrey Howe Outstanding Contribution Award from the Canadian Society for Epidemiology and Biostatistics, the University of British Columbia’s Chew Wei Memorial Prize in Cancer Research, and the McLaughlin-Gallie Award from the Royal College of Physicians of Canada. He has mentored 115 graduate students and post-doctoral fellows, and 30 undergraduate trainees. He is Officer of the Order of Canada and Fellow of the Royal Society of Canada and of the Canadian Academy of Health Sciences. Heholds an honorary doctorate from Universidade Fernando Pessoa, Porto, Portugal.
- Expertise
- Cancer Biology
- Epidemiology and Global Health
- Medicine
- Research focus
- cancer epidemiology
- cancer prevention
- human papillomavirus
- cancer screening
- Experimental organism
- human
- Competing interests statement
- Entire research program funded by the Medical Research Council of Canada (until 1999), Canadian Institutes of Health Research (CIHR) (1999-present), National Institutes of Health, Canadian Cancer Society, and Cancer Research Society. He has received salary awards from the Fonds de Recherche Quebec Santé and CIHR. He holds a James McGill Professorship and the Minda de Gunzburg Endowed Chair at McGill University. He serves as Editor-in-Chief for Preventive Medicine and Preventive Medicine Reports and serves on the editorial boards of Cancer Epidemiology, Biomarkers & Prevention, International Journal of Cancer, Papillomavirus Research, and Salud Publica de Mexico. He has served as occasional consultant to companies involved with HPV vaccination (Merck and GSK) and HPV diagnostics (Roche, Abbott, Qiagen, and BD).
-
Wendy S Garrett
Harvard T.H. Chan School of Public Health, United States
Wendy Garrett is a Professor of Immunology and Infectious Diseases at the Harvard T. H. Chan School of Public Health, co-Director of the Harvard Chan Center for the Microbiome in Public Health, and an Associate Member of the Broad Institute. Her work explores host-microbiota interactions underlying mucosal immune homeostasis, gastrointestinal inflammatory disorders, and cancer. She graduated from the Yale College; received her MD PhD from Yale University and completed post-graduate training at Harvard.
- Expertise
- Immunology and Inflammation
- Microbiology and Infectious Disease
- Medicine
- Research focus
- host-microbiota interactions
- microbiome
- mucosal immunology
- Competing interests statement
- Wendy Garrett serves on advisory boards of Evelo Biosciences, Kintai Therapeutics, and Leap Therapeutics. She is a member of the Cell Reports and Journal of Clinical Microbiology editorial boards.
-
Diane M Harper
University of Michigan, United States
Diane M Harper, MD, MPH, MS, completed her undergraduate and graduate degrees at the Massachusetts Institute of Technology in Cambridge, Massachusetts, in the fields of Chemical Engineering and Polymerics. She received her medical and public health degrees from the University of Kansas in Kansas City, where she also did residencies in Gynecology/Obstetrics and Family Medicine. Dr Harper has spent the majority of her professional career at Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, as clinician, teacher and researcher in the Departments of Obstetrics and Gynecology, Community and Family Medicine and Women’s and Gender Studies, including improving life for LGBTQ.
She has received the Society of Teachers of Family Medicine (STFM) Excellence in Education Award and the Curtis Hames Research Award honoring her for changing medical care for women through evidence based research. She served as the Chair of Family and Geriatric Medicine at the University of Louisville during which time she also served on the United States Preventive Services Task Force.
She currently is a tenured Professor at the University of Michigan, serving as the Director for Research Management within the Michigan Institute of Clinical and Health Research, one of 50 Clinical and Translational Science Award Research Hubs across the United States. To date she has over 250 peer reviewed publications with over 27,000 citations, and over 40,000 downloads of her seminal review of HPV vaccines.
While at Dartmouth she developed and directed the Gynecologic Cancer Prevention Research Group based at the Norris Cotton Cancer Center in which research on all aspects of HPV associated diseases, specifically cervical cancer prevention was conducted. She is an internationally recognized expert on Human Papillomavirus, the cause of cervical cancer, and its prophylactic and therapeutic vaccines. She has published the seminal clinical research on HPV vaccines and lectured internationally in over 100 countries. She has served on NCI research committees, European research study sections, addressed the Council on Foreign Affairs, and served as a technical advisor to the World Health Organization. Dr Harper has been honored as one of the top clinicians in her field in the US, and Family Physician of the Year in New Hampshire in 2006.
- Expertise
- Medicine
- Epidemiology and Global Health
- Microbiology and Infectious Disease
- Immunology and Inflammation
- Research focus
- HPV associated diseases
- primary care
- women's health
- cancer precursor detection
- health behaviours
- epidemiology
- cancer screening
- Experimental organism
- human
- Competing interests statement
- Diane Harper has received funding from NCI, NCATS, NHLBI, CDC, multiple national philanthropic organizations, including the American Cancer Society, The Robert Wood Johnson Foundation, and the Susan G Komen Foundation, in addition to state and local funding agencies and collaborations with industry. She serves in editorship capacities on boards including the Annals of Family Medicine, Preventive Medicine Reports, PLoS ONE, and Gynecologic Oncology. She is a peer reviewer for The Lancet, The New England Journal of Medicine, JAMA, among other journals.
-
Carlos Isales
Medical College of Georgia at Augusta University, United States
Carlos Isales is from San Juan, Puerto Rico, where he graduated from the University of Puerto Rico School of Medicine and did his residency in Internal Medicine at the San Juan Veterans Administration Hospital. He completed a fellowship in Endocrinology and Metabolism at Yale University School of Medicine working in a laboratory under Dr Howard Rasmussen. In 1993, he moved to the Medical College of Georgia in Augusta, GA to help establish the Institute of Molecular Medicine and Genetics. His work has focused on defining the impact of nutrients on bone metabolism and loss of nutrient sensing with aging leading to both bone and muscle loss. His group was among the first to characterize an entero-osseous axis linking incretin hormones and bone turnover. Current work is focused on defining the impact of oxidation of aromatic amino acids and downstream metabolites such as tryptophan-kynurenine on stem cell proliferation and differentiation and resultant age-related osteoporosis. He is currently Chief of the Division of Endocrinology and Metabolism at Augusta University, Regents’ Professor and J. Harold Harrison Distinguished University Chair in Healthy Aging. He is also the Clinical Director of the newly established Center for Healthy Aging. His research is funded by the National Institutes of Aging. He is also passionate about mentoring the next generation of scientists and is MPI on a training award from the National Institutes on Aging.
- Expertise
- Medicine
- Research focus
- aging
- stem cells
- epigenetics
- metabolic bone disease
- nutrition
- amino acid metabolism
- tryptophan metabolism
- Experimental organism
- human
- mouse
- Competing interests statement
- Carlos Isales is currently funded by the National Institute on Aging. He is co-founder of Gerologix, a company focused on developing countermeasures to musculoskeletal aging. He is currently Academic Editor for PLOS ONE and JBMR Plus.
-
Caigang Liu
Shengjing Hospital of China Medical University, China
Caigang Liu received his PhD from the China Medical University, and trained clinically at first hospital of China Medical University. Then joined and served as a director of Breast Center Shengjing Hospital of China Medical University in 2016. His current research interests focus on clinical and translational research of oncology. In recent years, he has led a clinical research term to explore the improvement in breast reconstruction surgery and highly safe and effective anti-cancer strategies, along with identification of therapeutic targets and development of small molecular drugs against cancer metastasis. He has led several projects funded by the National Natural Science Foundation, including the discovery of FSIP1 as a new target for anti-HER2 treatment, and is developing a new strategy to reverse anti-HER2 resistance in breast cancer. He is a member of the National Micro-noninvasive Committee of Chinese Medical Association, a vice chairman of the first breast disease branch of China Sexology Association, and a member of the Standing Committee in breast cancer marker collaboration group of Chinese Anti-cancer Association.
- Expertise
- Medicine
- Cancer Biology
- Research focus
- surgical oncology
- oncological clinical trials
- breast cancer translational medicine
- cancer metastasis and drug resistance
- small molecular drug development
- Experimental organism
- human
- mouse
- Competing interests statement
- Caigang Liu is currently funded by the National Natural Science Foundation of China and “Top young talent” project of Liaoning province, China. He now holds a number of patents for anti-tumor small molecular drugs and Traditional Chinese Medicine.
-
Shlomo Melmed
Cedars-Sinai Medical Center, United States
Shlomo Melmed MD's career has focused on integrating basic science discovery with prospective study of patients with pituitary disease. He has trained more then 70 pre- and post-doctoral trainees. His laboratory is at the forefront of pituitary discovery, focusing on the study of the pathogenesis and treatment of pituitary tumors. Fundamental discovery achievements include elucidating intrapituitary signaling mechanisms underlying excess tumor-derived GH, ACTH or PRL secretion; identification of novel subcellular therapeutic targets for drug application in clinical trials; understanding the relationship between tumor cell proliferation and GH hypersecretion and peripheral GH actions. Dr Melmed and colleagues have applied these findings to understanding cell cycle mechanisms underlying the extraordinarily rare transformation of these invariably benign adenomas to malignancy. They have coupled these translational discoveries with leading scholarly roles in developing clinical guidelines, pivotal investigator-initiated clinical trials, and original disease classification for pituitary medicine.
- Expertise
- Medicine
- Cancer Biology
- Research focus
- endocrinology
- pituitary medicine
- endocrine tumors
- Competing interests statement
- Shlomo Melmed MD edits The Pituitary, and co-edits the Williams Textbook of Endocrinology; he is Editor-in-Chief of Pituitary and post-Editor-in-Chief of Endocrinology. He was President of the Pituitary Society, and of International Society of Endocrinology and is a director of the California Institute of Regenerative Medicine. His laboratory is funded by the NIH.
-
Tony Ng
King's College London, United Kingdom
Tony Ng (FMEDSCI, MB ChB, MRCP, FRCPath, PhD) brings a rich spectrum of knowledge and capabilities with clinical experience in treating AIDS patients (with opportunistic infections and cancers) and fundamental immunology skills. He is also a pioneer of molecular imaging in cancer. He was the first person to use antibody based fluorescence lifetime imaging (FLIM) approaches in tumour cells and tissues to monitor protein states and function. He has published on how to visualize protein biochemistry in preclinical models; as well as in patient-derived cancer tissues for establishing in vitro/ companion diagnostics. He has adopted a multidisciplinary approach to understand cancer recurrence and also to stratify molecularly targeted agents in combination with immunotherapy. His research bridges the gap between physics, biology and medicine, particularly in the field of translational cancer research.
For clinical translation, he has the proven ability to coordinate and work cooperatively with colleagues and leaders in a wide variety of disciplines (imaging, cell biology, oncology, bioinformatics, surgery, pathology, genomics, as well as physical science disciplines such as mathematics, physics, chemistry and engineering). He has directed the KCL and UCL Comprehensive Cancer Imaging Centre (CCIC, one of four centres funded by CRUK & EPSRC in the UK) since its inception in 2008. The vision for the CCIC is to develop novel imaging (PET and MRI) technologies and use them in combination with clinicopathological assessment, genomics and in-house nanoscopic imaging to measure protein interactions in the context of interventional trials. In such trial context, the tissue imaging (FLIM histology) approach he has developed and refined over the years is beginning to reveal ErbB/ HER receptor rewiring as a mechanism of resistance in human tumours under selection pressure such as cetuximab.
Tony Ng is the current Director of the Comprehensive Cancer Centre, part of the KCL School of Cancer & Pharmaceutical Sciences, and the National Institute for Health and Care Research (NIHR) Guy’s & St Thomas’ Biomedical Research Centre (BRC) Cancer Theme. In 2022, he joined GSK on a part-time basis, to help establish the GSK-KCL Translational Oncology Research Hub which was which was announced in September 2021. The aim is to apply his clinical medicine training as well as immunology, biochemistry and imaging expertise to accelerate the development of the anti-cancer drugs. HIs experience of collaborating with mathematicians/theoretical physicists creates an opportunity to bridge the biology & AI/ML interface, an essential component of delivering the innovative Digital biological twin vision.
Training/expertise: Medicine, Immunology, Cancer cell biology, Biochemistry and Optical Imaging/Biophysics as well as preclinical Radionuclide imaging.
- Expertise
- Medicine
- Cancer Biology
- Immunology and Inflammation
- Research focus
- imaging
- biomarkers
- trial
- immune
- cancer
- reverse translation
- exosome
- organoid
- tumour microenvironment
- Competing interests statement
- At KCL, Tony Ng receives funding from Cancer Research UK, Medical Research Council, Wellcome Leap Inc., European Commission and GSK. He is employed on a part time basis as the Vice President of the Digital biological twin Unit at GSK.
-
Paul W Noble
Cedars-Sinai Medical Centre, United States
Paul W Noble, MD is a physician-scientist at the Cedars-Sinai Medical Center in Los Angeles where he is a Professor of Medicine and Chair of the Department of Medicine. He attended Haverford College and received his MD from New York University. After internal medicine residency and chief residency, he trained in pulmonary and critical care medicine at the University of Colorado and the National Jewish Center in Denver where he did his research fellowship with David Riches and Peter Henson and gained expertise in interstitial lung diseases. He has held faculty positions at the Johns Hopkins Hospital and Yale University School of Medicine where he was a tenured Professor and started the interstitial lung disease clinics at both institutions. He then moved to Duke University where he was a tenured Professor and Chief of the Division of Pulmonary, Allergy and Critical Medicine before moving to Cedars-Sinai in 2013.
His laboratory has focused on the cellular and molecular mechanisms of unremitting lung inflammation and fibrosis. He defined the roles of endogenous matrix degradation products and host defense in regulating persistent lung inflammation. Over the last decade he has focused on mechanisms the lead to fibroblast activation and invasion in severe pulmonary fibrosis and the failure of alveolar progenitor cell renewal in idiopathic pulmonary fibrosis (IPF). He has also played a significant role in the clinical trial development of the only FDA-approved treatments for IPF. He still maintains an active clinical practice. His laboratory has been funded by the NIH since 1992. He is an elected member of the American Society of Clinical Investigation, Interurban Clinical Club and the Association of American Physicians where he currently serves on Council.
- Expertise
- Medicine
- Research focus
- pulmonary medicine
- critical care
- lung inflammation
- fibrosis
- host defense
- clinical trials
- epithelial cell biology
- fibroblast biology
- Experimental organism
- human
- mouse
- Competing interests statement
- The Noble Laboratory is supported by the National Institutes of Health (National Heart, Lung and Blood Institute (NHLBI) and National Institute of Allergy and Infectious Diseases (NIAID).
-
Martin Pollak
Harvard Medical School, United States
Martin Pollak, MD is the Chief for the Division of Nephrology and the George C. Reisman Professor of Medicine with Harvard Medical School.
Dr Pollak is a graduate of Princeton University and the New York University School of Medicine. He did clinical training in Internal Medicine at Columbia-Presbyterian Medical Center, completed a nephrology fellowship at the Brigham and Women’s Hospital, followed by postdoctoral research training in the Department of Genetics at Harvard Medical School in the laboratory of Jon and Christine Seidman. Dr. Pollak’s laboratory is interested in the molecular genetic basis of human kidney disease, with a particular focus on diseases of the glomerulus. His laboratory uses a combination of methods, including human genetics, mouse genetics, cell biology, and biochemical tools to understand the connection between phenotype and genotype and to understand glomerular physiology.
He was elected a member of the National Academy of Sciences in 2014, and received the American Society of Nephrology Homer W. Smith Award in 2017.
- Expertise
- Medicine
- Genetics and Genomics
- Research focus
- nephrology
- genetics
- kidney
- glomerulus
- Experimental organism
- human
- mouse
- Competing interests statement
- Dr Pollak receives funding from the National Institutes of Health (NIH), the United States Department of Defense, and Vertex Pharmaceuticals. He is an Associated Editor for the Journal of the American Society of Nephrology and an ad hoc editor for PNAS.
-
W Kimryn Rathmell
Vanderbilt University Medical Center, United States
Dr Kimryn Rathmell is the Chair of Medicine and Physician-in-Chief at Vanderbilt University Medical Center. She is a physician-scientist studying the molecular biology of renal cell carcinomas and rare tumors of the kidney. She earned her MD and PhD in Biophysics at Stanford University. She completed internal medicine training at the University of Chicago and the University of Pennsylvania, and fellowship in medical oncology at the University of Pennsylvania. She joined Vanderbilt in 2015 to lead the Division of Hematology and Oncology.
Her research program focuses on understanding the molecular pathogenesis of renal cell carcinomas and spans early models of renal tumorigenesis, novel imaging strategies for diagnosis and screening of kidney cancer, epigenetic regulation of kidney cancers, metabolic features of tumorigenesis, and novel therapeutic strategies to overcome resistance to anti-angiogenic therapy and checkpoint targeted immunotherapy. With these bench to bedside strategies, her laboratory endeavors to integrate knowledge of pathways that promote cancer development with translational clinical studies, and uses these discoveries to develop robust approaches to improve the survival of patients with kidney cancers. She serves as the Deputy Director for Research Integration and Career Development for the Vanderbilt-Ingram Cancer Center and on the Board of Scientific Advisors for the National Cancer Institute.
- Expertise
- Cancer Biology
- Medicine
- Research focus
- cancer biology
- molecular biology
- epigenetics
- biomarkers
- angiogenesis
- Competing interests statement
- Stock and Other Ownership Interests
Company: Sitryx (Recipient: An Immediate Family Member); Company: Caribou Publishing (Recipient: An Immediate Family Member); Company: Nirogy Therapeutics (Recipient: An Immediate Family Member)Honoraria
Company: Merck (Recipient: An Immediate Family Member); Company: Pfizer (Recipient: An Immediate Family Member)Consulting or Advisory Role
Company: Sitryx (Recipient: An Immediate Family Member); Company: caribou Biosciences (Recipient: An Immediate Family Member)Research Funding
Company: Incyte (Recipient: An Immediate Family Member); Company: Calithera Biosciences (Recipient: An Immediate Family Member); Company: Tempus (Recipient: An Immediate Family Member); Company: Peloton Therapeutics (Recipient: Institution); Company: Pfizer (Recipient: Institution); Company: Genentech (Recipient: Institution); Company: E.R. Squibb Sons, LLC (Recipient: Institution)Patents, Royalties, Other Intellectual Property
ClearCode34 Risk prediction biomarker for kidney cancer; hERV 3-2 expression as a biomarker of response to immunotherapyOpen Payments Link
-
Jonathan Roiser
University College London, United Kingdom
Jonathan Roiser is Professor of Neuroscience and Mental Health and Deputy Director at the UCL Institute of Cognitive Neuroscience. His research interests lie in understanding the brain and psychological processes driving mental health problems, especially disrupted motivation in depression. He has published over 150 peer-reviewed papers and his recent research has been funded by Wellcome, the MRC, the Leverhulme Trust and the Rosetrees Trust. He founded and directs two PhD schemes: the UCL-NIMH Joint Doctoral Training Program in Neuroscience and the UCL Wellcome 4-year PhD Programme in Mental Health Science.
- Expertise
- Neuroscience
- Medicine
- Research focus
- mental health
- neuroimaging
- behavior
- psychopharmacology
- computational modelling
- Experimental organism
- human
- Competing interests statement
- I hold active grants from Rosetrees, Wellcome and the Leverhulme Trust. I supervise an ongoing PhD studentship co-funded by MRC and Cambridge Cognition Ltd. I have performed paid consultancy work for GE Ltd within the last 3 years. I sit on the Editorial Board of Current Opinion in Behavioral Sciences.
-
Lois Smith
Harvard Medical School, Children's Hospital Boston, United States
Lois EH Smith MD, PhD is an ophthalmologist and clinician/scientist at Boston Children’s Hospital and Professor of Ophthalmology at Harvard Medical School. Her basic research work is in retinal neovascularization, both basic mechanism and treatment including diabetic retinopathy, retinopathy of prematurity, age-related macular degeneration and retinitis pigmentosa.
She has a long standing interest in eye diseases particularly retinopathy of prematurity, diabetic retinopathy, and AMD and in the mechanisms behind these diseases, particularly the underlying causes of neovascularization and the interactions between neurons and vessels. Many pathways that they have found have been translated into clinical trials, including replacement of IGF-1 in preterm infants and treatment of AMD with anti-VEGF antibodies in which they were the first to show the benefit of blocking VEGF in a mouse model of retinopathy. More recently Dr Smith's work has been interested in metabolic function in photoreceptors, particularly with respect to lipids. Photoreceptor metabolic dysfunction causes central vision loss in retinal degenerative diseases (including ROP) but is also implicated in age-related macular degeneration and diabetic retinopathy.
Dr Smith is the recipient of the Friedenwald award, the Alcon Research Institute award, the Silverman award, and the Bressler Prize.
- Expertise
- Developmental Biology
- Medicine
- Neuroscience
- Research focus
- age-related macular degeneration
- diabetic eye disease
- retinopathy
- ocular disease
- developmental neuroscience
- Competing interests statement
- Dr Smith has received funding from the National Eye Institute, Massachusetts Lions Eye Research Fund, the European Union, the Lowy Medical Research Institute, Foundation Fighting Blindness, Research to Prevent Blindness Senior Investigator Award, and the Alcon Award.Current editor roles include: Editor for Ophthalmology (Science), Editor for Journal of Clinical Ophthalmology, and Editor IOVS (Investigative Ophthalmology and Visual Science).
-
Hiroshi Takayanagi
The University of Tokyo, Japan
Hiroshi Takayanagi, MD, PhD graduated from the Faculty of Medicine, University of Tokyo in 1990. Originally trained as an orthopaedic surgeon and rheumatologist in the Department of Orthopaedic Surgery, University of Tokyo, Dr Takayanagi began his basic research career in 1996. He was awarded his PhD in 2001 by the University of Tokyo and became Assistant Professor at the Department of Immunology where he studied the regulation of bone metabolism by the immune system by focusing on the control of osteoclast differentiation. In 2012, he was promoted to Professor, Department of Immunology, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo. Dr Takayanagi received the 2019 Japan Academy Prize for his studies on osteoimmunology.
- Expertise
- Immunology and Inflammation
- Medicine
- Research focus
- arthritis
- osteoporosis
- immune tolerance
- osteoimmunology
- autoimmunity
- fibroblast
- osteoclast
- T cells
- Competing interests statement
- Hiroshi Takayanagi has received funding from the Ministry of Education, Culture, Sports, Science & Technology, the Japan Agency for Medical Research and Development, and Japan Society for the Promotion of Science.He is an Editorial Board Member of Annals of the Rheumatic Diseases and Bone Research, an Associate Editor of Inflammation and Regeneration and Journal of Bone and Mineral Metabolism, and a Transmitting Editor of Modern Rheumatology.
-
Jos WM van der Meer
Radboud University Medical Centre, Netherlands
Jos WM van der Meer is emeritus Professor of Medicine at Radboud University Nijmegen, The Netherlands. Between 1992 and 2012 he was head of the Department of internal medicine at the Radboud University Medical Centre. His major areas of expertise are host defence against infection, trained immunity, autoinflammation, immunodeficiency and antimicrobial policy.
- Expertise
- Medicine
- Microbiology and Infectious Disease
- Research focus
- infectious disease and host defense
- innate immunity
- trained immunity
- immunodeficiency
- autoinflammatory diseases
- chronic fatigue syndrome
- Experimental organism
- human
- mouse
- Competing interests statement
- Jos WM van der Meer is a member of the Royal Netherlands Academy of Arts and Sciences (KNAW), for which he served as a vice-president from 2005 to 2011. He is a member of Academia Europaea and he is past-president of EASAC, the European Academies Science Advisory Council. He is an honorary Fellow of the Royal College of Physicians in London and in Edinburgh and a fellow of the Infectious Diseases Society of America and of the European Society of Clinical Microbiology and Infectious diseases. He is a member of the Dutch National Board for Research Integrity LOWI. He received a number of prices and awards, such as the Gold Hijmans van den Bergh medal. He was awarded knighthood in the order of the Netherlands Lion in 2003.
-
Gary Westbrook
Vollum Institute, United States
Gary Westbrook is a Senior Scientist at the Vollum Institute and Rocky and Julie Dixon Professor of Neurology at Oregon Health & Science University. Dr. Westbrook is a member of the National Academy of Medicine (formerly Institute of Medicine), the American Academy of Arts and Sciences, and past editor-in-chief of the Journal of Neuroscience. He has received Javits and Merit awards from NIH for his research as well as an International Cooperation Award from the Max Planck Society. Dr. Westbrook received his medical training and did graduate study in Biomedical Engineering at Case Western Reserve University, followed by residencies in Internal Medicine and Neurology, and basic neuroscience research at the National Institutes of Health in Bethesda. Earlier work in his lab was mostly directed at the level of receptors, particularly N-methyl-D-aspartate (NMDA) receptors, and the function of single synapses. The emphasis has now largely shifted to studies of small networks (microcircuits) in the hippocampus. Dr. Westbrook maintains interests in clinical neurology, particularly epilepsy, as well as graduate research training. He was co-Director of the Vollum Institute (2005-2015) and director of the Neuroscience Graduate Program at Vollum/OHSU (2008-2018).
- Expertise
- Neuroscience
- Medicine
- Research focus
- synaptic transmission
- synaptic plasticity
- ligand-gated ion channels
- hippocampus
- olfactory bulb
- epilepsy
- in vitro physiology
- activity-dependent gene expression
- Experimental organism
- mouse
- Competing interests statement
- Gary Westbrook is employed by Oregon Health and Science University. He receives research and training funding from the National Institutes of Health and the Ellison Medical Foundation. He is a member of the National Academy of Medicine (formerly Institute of Medicine) and the American Academy of Arts and Sciences. He serves on Scientific Advisory Boards for Max Planck Institutes in Göttingen (MPIEM) and Florida (MPFI), the Myelin Repair Foundation, and on study sections for the National Institutes of Health. He is currently a member of editorial boards for Physiological Reviews and Philosophical Transactions of the Royal Society B.
-
Richard M White
Memorial Sloan Kettering Cancer Center, United States
Richard White, M.D., Ph.D, is a physician-scientist at the Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College. He is interested in basic mechanisms underlying metastasis, using the zebrafish as a model system. His work has established numerous techniques for cancer modeling and high-resolution imaging in the fish. Using these tools, the lab is focused on the cross-talk between tumor cells and the microenvironment, and how this interplay influences metastatic success. His work has revealed novel interactions between melanoma cells and adipocytes in the microenvironment, and how neural crest programs play roles in melanoma progression. He has been awarded the NIH Director’s New Innovator Award, the Pershing Square Foundation Award, and the Mark Foundation ASPIRE award.
- Expertise
- Cancer Biology
- Cell Biology
- Developmental Biology
- Medicine
- Research focus
- development
- neural crest
- zebrafish
- cancer
- melanoma
- metastasis
- microenvironment
- Experimental organism
- zebrafish
- Competing interests statement
- Richard White receives funding from the National Institutes of Health, the Pershing Square Sohn Foundation, the Mark Foundation, the Melanoma Research Alliance, the American Cancer Society and the Harry J. Lloyd Foundation. He receives consulting fees from N-of-One, Inc.
-
Ma-Li Wong
State University of New York Upstate Medical University, United States
Ma-Li Wong, MD, PhD, FRANZCP, is Professor in the Department of Psychiatry and Behavioral Sciences, and Neurosciences and Physiology at SUNY Upstate Medical University. She was born in Hong Kong and grew up in Brazil, where she graduated from the University of São Paulo School of Medicine (FMUSP). She had clinical and research training in psychiatry at Albert Einstein College of Medicine, NIH, and Yale University. Ma-Li Wong is a bench, clinical and translational researcher in the biology of depression and co-morbid conditions, chronic stress, and antidepressant drugs. She has conducted research for over 30 years at Yale (Chief Resident and Instructor), National Institutes of Health (Unit Chief), University of California, Los Angeles (Professor), University of Miami (Professor and Vice-Chair), and in Australia (Australian National University, South Australian Health and Medical Research Institute, and Flinders University). She was the recipient of the following awards: Milton Rosenbaum Award for Psychiatric Research (1989); Lilly Psychiatric Research Fellowship by the American Psychiatric Association (1990); SmithKline Beecham Award by the Society of Biological Psychiatry (1990); APA/Dista Research Award (1993); NIH Fare Award (1996 and 1997); Henry L. Moses Award by the Montefiore Medical Center (1998). She co-edited two books: Pharmacogenomics: The Search for Individualized Therapeutics (2002) and Biology of Depression: From Novel Insights to Therapeutic Strategies (2005).
- Expertise
- Medicine
- Neuroscience
- Research focus
- major depression
- chronic stress
- neuroinflammation
- neuroendocrinology
- pharmacogenomics
- genetics
- obesity
- leptin
- Experimental organism
- human
- mouse
- primary cells
- immortalized cells
- Competing interests statement
- Ma-Li Wong is an Associate Editor for Molecular Psychiatry. She has been funded by organizations such as the NIH in the US and the National Health and Medical Research Council in Australia.
-
Mone Zaidi
Icahn School of Medicine at Mount Sinai, United States
Mone Zaidi graduated in medicine from King George’s Medical College, India, and trained clinically at the Hammersmith Hospital, London, under the tutelage of Iain MacIntyre, FRS. After obtaining a PhD and MD from the University of London, Dr Zaidi held appointments as Lecturer at the Royal Postgraduate Medical School and Senior Lecturer and Honorary Consultant at St. George’s Hospital Medical School for over 8 years. In 1999, he moved to Mount Sinai School of Medicine in New York as Professor of Medicine and Founding Director of The Mount Sinai Bone Program. Zaidi has discovered mechanisms of skeletal homeostasis in health and its dysregulation in common and rare diseases. These studies, spanning over 30 years, included the first description of calcium sensing in the osteoclast and the discovery that locally released nitric oxide acts to suppress bone removal. In 2003, his group published evidence for a pituitary–bone axis of medical significance, in which pituitary hormones affect the skeleton directly. More recently, he found that inhibiting FSH not only increased bone mass, but also reduced body fat and increased thermogenesis – in essence, laying the firm foundation for his new humanized monoclonal FSH antibody to treat both osteoporosis and obesity. This corpus of work was selected by Nature Medicine as one of eight “Notable Advances” in biomedicine for 2017. Zaidi’s research was funded by the Medical Research Council of the UK, and since 1997, by the US National Institutes of Health. He is an elected member of the American Society for Clinical Investigation, Association of American Physicians, the Interurban Clinical Club (established by Sir William Osler in 1905) of which he was President, the Practitioners’ Society of New York (the oldest medical society in the US), and the Association of Professors of Medicine. Zaidi was made Master of the American College of Physicians, received the Harrington Scholar-Innovator Award, was elected as Fellow of the American Association of Advancement of Science, and is recipient of three honorary doctorates.
- Expertise
- Medicine
- Research focus
- osteoporosis
- obesity
- bone mass
- metabolism
- adipose tissue
- endocrine physiology
- pituitary hormones
- FSH
- Competing interests statement
- Mone Zaidi is currently funded by the National Institute on Aging and the National Institute of Diabetes, Digestive and Kidney Diseases of the NIH. He is inventor on several patents in relation to his work on FSH, bone and body composition. He is currently Consulting Editor for the Journal of Clinical Investigation, Editor of a series – Marrow – of the Annals of the New York Academy of Sciences, and Editor-in-chief of the Encyclopedia of Bone Biology, published by Elsevier as their Major Reference Works.
Reviewing editors
-
Yousef Abu-Amer
Washington University School of Medicine, United States
- Expertise
- Cell Biology
- Immunology and Inflammation
- Medicine
- Research focus
- osteolysis
- osteoclast
- osteoarthritis
- osteoimmunology
- inflammatory arthritis
- RANKL
-
Cheryl Ackert-Bicknell
University of Colorado, United States
- Expertise
- Medicine
- Genetics and Genomics
- Research focus
- bone
- bone biology
- genetics
- musculoskeletal
- aging
- Experimental organism
- mouse
- rat
-
Iannis E Adamopoulos
Harvard Medical School, United States
- Expertise
- Immunology and Inflammation
- Medicine
- Research focus
- osteoclasts
- arthritis
- psoriatic arthritis
- interleukin 23
- interleukin 17
- RANKL
-
Anurag Agrawal
CSIR Institute of Genomics and Integrative Biology, India
- Expertise
- Medicine
- Research focus
- asthma
- respiratory diseases
- Experimental organism
- human
- mouse
-
Olujimi A Ajijola
University of California, Los Angeles, United States
- Expertise
- Medicine
- Research focus
- cardiovascular
- neurobiology
- sympathetic nerves
- ventricular arrhythmias
- RNA sequencing
-
David B Allison
Indiana University, United States
- Expertise
- Medicine
- Genetics and Genomics
- Epidemiology and Global Health
- Computational and Systems Biology
- Evolutionary Biology
- Research focus
- experimental design
- statistics
- longevity
- biostatistics
- obesity
- nutrition
- senescence
- research rigour
- science integrity
-
Joon-Yong An
Korea University, South Korea
- Expertise
- Medicine
- Computational and Systems Biology
- Genetics and Genomics
- Neuroscience
- Research focus
- whole genome sequencing
- noncoding mutation
- neurodevelopment
- autism spectrum disorders
- multi-omics
-
Cynthia L Andoniadou
King's College London, United Kingdom
- Expertise
- Developmental Biology
- Medicine
- Stem Cells and Regenerative Medicine
- Research focus
- stem cells
- endocrine
- pituitary gland
- adrenal gland
- paracrine signalling
- tumours
- Experimental organism
- human
- mouse
-
Wadih Arap
Rutgers Cancer Institute of New Jersey at University Hospital, United States
- Expertise
- Medicine
- Cancer Biology
- Research focus
- clinical oncology
- genitourinary (GU) cancers
- prostate cancer
-
Hossein Ardehali
Northwestern University, United States
- Expertise
- Medicine
- Biochemistry and Chemical Biology
- Research focus
- mitochondria
- iron
- glucose metabolism
- mRNA-binding proteins
- hexokinases
- metabolism
- cardiac biology
-
Mohammad Athar
University of Alabama at Birmingham, United States
- Expertise
- Medicine
- Research focus
- dermatology
- skin diseases
- skin biochemistry
- skin cancer
-
Robert Baiocchi
The Ohio State University, United States
- Expertise
- Medicine
- Cancer Biology
- Immunology and Inflammation
- Research focus
- Epstein Barr Virus
- lymphoma
- cancer therapeutics
- cancer vaccines
- cancer immunology
- cancer immunotherapy
- cancer epigenetics
-
Muthuswamy Balasubramanyam
ICMR Emeritus Scientist, Madras Diabetes Research Foundation, India
- Expertise
- Medicine
- Biochemistry and Chemical Biology
- Cancer Biology
- Cell Biology
- Developmental Biology
- Epidemiology and Global Health
- Genetics and Genomics
- Immunology and Inflammation
- Neuroscience
- Stem Cells and Regenerative Medicine
- Research focus
- disease biology
- diabetes
- aging
- omnics
- calcium signaling
- endocrine disruptors
- probiotics
- molecular medicine
-
Audrey M Bernstein
State University of New York Upstate Medical University, United States
- Expertise
- Cell Biology
- Medicine
- Stem Cells and Regenerative Medicine
- Research focus
- cornea
- scarring
- fibrosis
- glaucoma
- integrins
- myofibroblast
-
José Biurrun Manresa
National Scientific and Technical Research Council (CONICET), National University of Entre Ríos (UNER), Argentina
- Expertise
- Medicine
- Neuroscience
- Research focus
- pain
- nociceptive system
- EEG
- EMG
- biomedical signal processing
- biostatistics
-
Jonathan S Bogan
Yale School of Medicine, United States
- Expertise
- Medicine
- Cell Biology
- Research focus
- insulin
- protein trafficking
- metabolism
- type 2 diabetes
-
Marc J Bonten
University Medical Center Utrecht, Netherlands
- Expertise
- Epidemiology and Global Health
- Microbiology and Infectious Disease
- Medicine
- Research focus
- epidemiology
- antibiotic resistance
- healthcare-associated infections
- prevention
- clinical trials
-
Philip Boonstra
University of Michigan, United States
- Expertise
- Medicine
- Epidemiology and Global Health
- Cancer Biology
- Genetics and Genomics
- Research focus
- biostatistics
- clinical trials
- cancer biostatistics
- epidemiology
- ECMO
- statistical programming
-
Annelien Bredenoord
University Medical Centre Utrecht, Netherlands
- Expertise
- Medicine
- Research focus
- bioethics
- medical ethics
- ethics
-
Christoph Buettner
Rutgers Robert Wood Johnson Medical School, United States
- Expertise
- Medicine
- Research focus
- metabolism
- diabetes
-
Christopher Cardozo
Icahn School of Medicine at Mount Sinai, United States
- Expertise
- Medicine
- Research focus
- spinal cord injury
- muscle biology
- sarcopenia
- muscle physiology
- Experimental organism
- mouse
- rat
-
Dirce M Carraro
AC Camargo Cancer Center, Brazil
- Expertise
- Medicine
- Cancer Biology
- Research focus
- oncology
- cancer genomics
-
Alesha Castillo
New York University Bioengineering Institute, United States
- Expertise
- Medicine
- Stem Cells and Regenerative Medicine
- Research focus
- bone
- mechanobiology
- mechanical loading
- fracture repair
- skeletal stem and progenitor cells
- osteoblasts
- osteogenesis
- aging
-
Howard Y Chang
Stanford University, United States
- Expertise
- Medicine
- Chromosomes and Gene Expression
- Genetics and Genomics
- Research focus
- cancer
- immunotherapy
- RNA
- genomics
- epigenomics
- dermatology
- Experimental organism
- human
- mouse
-
Snigdha Chaturvedi
University of North Carolina, Chapel Hill, United States
- Expertise
- Medicine
- Research focus
- nature language processing
- narrative understanding
-
Hina W Chaudhry
Icahn School of Medicine at Mount Sinai, United States
- Expertise
- Medicine
- Stem Cells and Regenerative Medicine
- Research focus
- cardiac regeneration
- cardiomyocytes
- developmental genetics
- stem cell biology
- regenerative biology
-
Di Chen
Shenzhen Institute of Advanced Technology, China
- Expertise
- Medicine
- Research focus
- bone disease
-
Iacopo Chiodini
Ospedale Niguarda Ca' Granda, Italy
- Expertise
- Medicine
- Research focus
- adrenal gland
- bone metabolism
- osteoporosis
- calcium metabolism
- bone fragility
-
Jungmin Choi
Korea University College of Medicine, South Korea
- Expertise
- Cancer Biology
- Computational and Systems Biology
- Genetics and Genomics
- Medicine
- Research focus
- rare disorders
- single cell genomics
- computational biology
- human genomics
-
Sarah E Cobey
University of Chicago, United States
- Expertise
- Microbiology and Infectious Disease
- Ecology
- Evolutionary Biology
- Epidemiology and Global Health
- Medicine
- Research focus
- B cells
- coevolution
- infectious disease dynamics
- influenza
- mathematical modelling
- vaccination
-
Graziana Colaianni
University of Bari, Italy
- Expertise
- Medicine
- Cell Biology
- Stem Cells and Regenerative Medicine
- Research focus
- bone
- osteoporosis
- muscle
- sarcopenia
- cartilage
- muscle atrophy
- Experimental organism
- mouse
- human
-
Yali Cong
Peking University Health Science Center, China
- Expertise
- Medicine
- Research focus
- medical ethics
- bioethics
-
Alex R Cook
National University of Singapore, Singapore
- Expertise
- Epidemiology and Global Health
- Microbiology and Infectious Disease
- Medicine
- Research focus
- infectious disease epidemiology
- mathematical modelling
- biostatistics
- health policy
-
Seth J Corey
Cleveland Clinic, United States
- Expertise
- Cancer Biology
- Medicine
- Research focus
- myeloid malignancies
- inherited or acquired bone marrow failure
- neutrophils
- platelets zebrafish
- cancer evolution
- proteostasis
-
Jennifer Cullen
Case Western Reserve University, United States
- Expertise
- Epidemiology and Global Health
- Medicine
- Research focus
- cancer population sciences
-
Ilse S Daehn
Icahn School of Medicine at Mount Sinai, United States
- Expertise
- Medicine
- Cell Biology
- Research focus
- mitochondria
- glomerular disease
- podocyte
- endothelial cells
- reactive oxygen species
-
Emek Demir
Oregon Health and Science University, United States
- Expertise
- Cancer Biology
- Computational and Systems Biology
- Genetics and Genomics
- Medicine
- Research focus
- proteomics
-
Alok Dhawan
Centre of Biomedical Research, India
- Expertise
- Medicine
- Ecology
- Research focus
- molecular epidemiology
- DNA damage and repair
- genetic toxicology
- nanomaterial toxicology
- environmental health
-
Rajan Dighe
Indian Institute of Science Bangalore, India
- Expertise
- Medicine
- Research focus
- reproductive endocrinology
-
Ana Domingos
University of Oxford, United Kingdom
- Expertise
- Medicine
- Neuroscience
- Research focus
- metabolism
- obesity
- neuroimmunity
- autonomic nervous system
- eating behaviour
- inflammation
-
Hannelore Ehrenreich
Max Planck Institute of Experimental Medicine, Germany
- Expertise
- Genetics and Genomics
- Immunology and Inflammation
- Medicine
- Neuroscience
- Research focus
- translational neuroscience
- erythropoietin
- hypoxia
- neuropsychiatric phenotypes
- deep phenotyping
- autoantibodies
- Experimental organism
- human
-
Joel K Elmquist
UT Southwestern Medical Center, United States
- Expertise
- Neuroscience
- Medicine
- Genetics and Genomics
- Research focus
- metabolism
- obesity
- diabetes
- hypothalamus
- feeding
- autonomic
- exercise
- Experimental organism
- mouse
- D. melanogaster
-
Noriaki Emoto
Kobe Pharmaceutical University, Japan
- Expertise
- Medicine
- Research focus
- cardiology
- pulmonary hypertension
- endothelin
- pharmacology
- vascular biology
-
John Ewer
Universidad de Valparaiso, Chile
- Expertise
- Developmental Biology
- Neuroscience
- Genetics and Genomics
- Medicine
- Research focus
- animal behaviour
- neuropeptides
- circadian clocks
- insect endocrinology
- Experimental organism
- D. melanogaster
-
Alberto Falchetti
Istituto Auxologico Italiano , IRCCS, Italy
- Expertise
- Medicine
- Research focus
- metabolic bone disease
- Paget's disease of bone
- familial primary hyperparathyroidism
- multiple endocrine neoplasia type 1
-
Edward A Fisher
New York University Grossman School of Medicine, United States
- Expertise
- Medicine
- Cell Biology
- Research focus
- preventive cardiology
- cardiology
- lipoprotein metabolism
- atherosclerosis
- Experimental organism
- mouse
-
Jonathan Flint
University of California, Los Angeles, United States
- Expertise
- Genetics and Genomics
- Medicine
- Research focus
- genetics
- genomics
- psychiatric disorders
-
Zhongjie Fu
Boston Children's Hospital/Harvard Medical School, United States
- Expertise
- Medicine
- Research focus
- retinal vasculature
- retinopathy
- adiponectin
-
Eric D Gaier
Boston Children's Hospital, United States
- Expertise
- Medicine
- Neuroscience
- Research focus
- ophthalmology
- amblyopia
- strabismus
-
Luigi Gennari
University of Siena, Italy
- Expertise
- Medicine
- Research focus
- metabolic bone disease
- Paget's disease of bone
- endocrinology
-
Gregory G Germino
National Institute of Diabetes and Digestive and Kidney Diseases, United States
- Expertise
- Medicine
- Genetics and Genomics
- Research focus
- nephrology
- genetic renal disease
- internal medicine
- ciliopathies
- Experimental organism
- mouse
- rat
- human
-
Evangelos J Giamarellos-Bourboulis
Attikon University Hospital, Greece
- Expertise
- Immunology and Inflammation
- Microbiology and Infectious Disease
- Genetics and Genomics
- Medicine
- Research focus
- sepsis
- hidradenitis suppurativa
- pathogenesis of infection
- biomarkers
-
David Ginsburg
University of Michigan, United States
- Expertise
- Medicine
- Genetics and Genomics
- Research focus
- hemostasis
- thrombosis
- protein secretion
- human genetics
- fibrinolysis
- Experimental organism
- human
- mouse
- zebrafish
-
Yelena Ginzburg
Icahn School of Medicine at Mount Sinai, United States
- Expertise
- Medicine
- Research focus
- iron metabolism
- erythropoiesis
- thalassemia
- myeloproliferative neoplasms
- hemochromatosis
- transferrin
- hepcidin
- erythroferrone
-
Joseph G Gleeson
The Rockefeller University, United States
- Expertise
- Medicine
- Neuroscience
- Developmental Biology
- Research focus
- neurodevelopmental disease
- brain development
- neurogenetics
- autism
- epilepsy
- intellectual disability
- organoid
- stem cells
- genomics
- bioinformatics
- Experimental organism
- human
- mouse
-
Pablo A González
Pontificia Universidad Católica de Chile, Chile
- Expertise
- Medicine
- Microbiology and Infectious Disease
- Research focus
- host-pathogen interactions
- dendritic cells
- T cells
- herpesviruses
- bacteria
- immune evasion
- viruses
- Experimental organism
- mouse
-
Ki Goosens
ki.goosens@mssm.edu, United States
- Expertise
- Neuroscience
- Medicine
- Research focus
- chronic stress
- translational science
- systems neuroscience
- brain-body interactions
-
Timothy D Griffiths
Newcastle University, United Kingdom
- Expertise
- Neuroscience
- Medicine
- Research focus
- auditory
- cognition
- neurology
- imaging
- Experimental organism
- human
- macaque
-
Yogesh K Gupta
The University of Texas Health Science Center at San Antonio, United States
- Expertise
- Medicine
- Structural Biology and Molecular Biophysics
- Cancer Biology
- Microbiology and Infectious Disease
- Research focus
- drug discovery
- nucleic acid modifications
- cancer epigenetics
- structures of viral proteins
- host-pathogen interactions
-
Adam Haber
Harvard TH Chan School of Public Health, United States
- Expertise
- Computational and Systems Biology
- Genetics and Genomics
- Medicine
- Research focus
- asthma
- machine learning
-
William C Hahn
Dana-Farber Cancer Institute, United States
- Expertise
- Cancer Biology
- Genetics and Genomics
- Medicine
- Research focus
- cancer
- transformation
- functional genomics
- RAS
- YAP1
- Experimental organism
- human
-
Shozeb Haider
University College London, United Kingdom
- Expertise
- Medicine
- Structural Biology and Molecular Biophysics
- Computational and Systems Biology
- Microbiology and Infectious Disease
- Research focus
- X-ray crystallography
- molecular dynamics simulations
- allostery
- structure-based drug design
- structural bioinformatics
- computational chemistry
- nucleic acids
- rare diseases
-
Sang Jun Han
Baylor College of Medicine, United States
- Expertise
- Medicine
- Cell Biology
- Research focus
- nuclear receptors
- steroid receptor coactivator
- endometriosis
- female infertility
-
Gaiti Hasan
Tata Institute of Fundamental Research, National Centre for Biological Sciences, India
- Expertise
- Genetics and Genomics
- Neuroscience
- Medicine
- Research focus
- calcium signaling
- motor function
- regulation of gene expression
- IP3R
- STIM
- Orai
- Experimental organism
- D. melanogaster
-
Shannon M Hawkins
Indiana University School of Medicine, United States
- Expertise
- Medicine
- Research focus
- endometriosis
- ovarian cancer
- endometrial cancer
-
Daniel Henrion
University of Angers, France
- Expertise
- Cell Biology
- Medicine
- Research focus
- vascular biology
- endothelium
- blood flow
- vascular remodeling
- hypertension
- blood pressure
- shear stress
- vascular diseases
-
Elizabeth P Henske
Brigham And Women's Hospital, United States
- Expertise
- Medicine
- Cancer Biology
- Research focus
- tuberous sclerosis complex
- lymphangioleiomyomatosis
- mTOR
- prostate cancer
-
Stephanie Hicks
Johns Hopkins Bloomberg School of Public Health, United States
- Expertise
- Medicine
- Computational and Systems Biology
- Genetics and Genomics
- Research focus
- single cell genomics
- statistics
- data science
- data analysis
- bioinformatics
- computational biology
- spatial genomics
-
Kenneth Ho
Garvan Institute of Medical Research, Australia
- Expertise
- Medicine
- Research focus
- metabolism
- sarcopenia
-
Patrick J Hu
Vanderbilt University School of Medicine, United States
- Expertise
- Medicine
- Developmental Biology
- Genetics and Genomics
- Research focus
- signal transduction
- genetics
- development
- aging
- cancer
- endoplasmic reticulum homeostasis
- dauer
- Experimental organism
- C. elegans
-
Christopher L-H Huang
University of Cambridge, United Kingdom
- Expertise
- Medicine
- Research focus
- cardiac arrhythmias
- atrial fibrillation
- skeletal muscle
- electrophysiology
- ion channels
- action potential propagation
- genetically modified mice
- patch clamping
- Experimental organism
- mouse
-
Susie Y Huang
Massachusetts General Hospital, United States
- Expertise
- Medicine
- Neuroscience
- Research focus
- development
- translation
- magnetic resonance imaging
-
Bradley Hyman
Massachusetts General Hospital, United States
- Expertise
- Medicine
- Neuroscience
- Research focus
- tau
- alzheimer
- neuropathology
-
Jameel Iqbal
Icahn School of Medicine at Mount Sinai, United States
- Expertise
- Medicine
- Research focus
- general pathology
- blood banking
- transfusion medicine
- transplantation immunology
- clinical pathology
-
Edward D Janus
University of Melbourne, Australia
- Expertise
- Epidemiology and Global Health
- Medicine
- Research focus
- cardiovascular disease
- diabetes
- prevention
- chronic diseases
- clinical guidelines
-
Jae-Wook Jeong
University of Missouri – Columbia, United States
- Expertise
- Medicine
- Cancer Biology
- Research focus
- estrogen
- endometriosis
- uterus
- endometrium
- endometrial cancer
- implantation
- decidualization
- progesterone
-
Prabhat Jha
Saint Michael's Hospital, Canada
- Expertise
- Epidemiology and Global Health
- Microbiology and Infectious Disease
- Medicine
- Research focus
- epidemiology
- global health
- infectious disease and population dynamics
- randomized controlled trials
-
Yaoting Ji
Wuhan University, China
- Expertise
- Medicine
- Stem Cells and Regenerative Medicine
- Cell Biology
- Research focus
- osteoporosis
- obesity
- stem cell differentiation
- aging
- beiging
- skeletal mineralization
- bone resorption
-
Jean Jiang
The University of Texas Health Science Center at San Antonio, United States
- Expertise
- Medicine
- Cell Biology
- Cancer Biology
- Research focus
- gap junctions
- hemichannels
- connexins
- bone biology
- osteocyte
- bone mechanobiology
- cancer bone metastasis
- lens biology
-
Mohammad M Karimi
Kings College London, United Kingdom
- Expertise
- Medicine
- Computational and Systems Biology
- Research focus
- bioinformatics
- genomics
- epigenomics
- transposable elements
- single-cell sequencing
- visual analytics
- epigenetic therapy
-
Gerard Karsenty
Columbia University, United States
- Expertise
- Genetics and Genomics
- Medicine
- Research focus
- endocrinology
- bone biology
- physiology
- bone endocrinology
-
Brian S Kim
Icahn School of Medicine at Mount Sinai, United States
- Expertise
- Medicine
- Immunology and Inflammation
- Neuroscience
- Research focus
- basophil
- cytokine
- innate lymphoid cell
- itch
- mast cells
- neuroimmunology
- sensory neuron
- somatosensation
-
Se-Min Kim
Icahn School of Medicine at Mount Sinai, United States
- Expertise
- Medicine
- Research focus
- metabolic bone disease
- diabetic bone disease
- thyroid bone disease
- phosphodiesterase (PDE)5
- PDE11
-
Melanie Königshoff
University of Colorado, United States
- Expertise
- Stem Cells and Regenerative Medicine
- Medicine
- Cell Biology
- Research focus
- lung regeneration
- wnt signaling
- pulmonary fibrosis
- chronic obstructive pulmonary disease
- epithelial cell biology
- Experimental organism
- human
- mouse
-
Smita Krishnaswamy
Yale School of Medicine, United States
- Expertise
- Medicine
- Research focus
- bioinformatics
- computational genomics
- immunology
- immunotherapy
- cancer
- neuroscience
- developmental biology
-
T Rajendra Kumar
University of Colorado, United States
- Expertise
- Cell Biology
- Developmental Biology
- Medicine
- Research focus
- reproductive endocrinology
- reproductive biology
- pituitary
- testis
- ovary
- Experimental organism
- mouse
-
Dan Larhammar
Uppsala University, Sweden
- Expertise
- Medicine
- Evolutionary Biology
- Neuroscience
- Cell Biology
- Chromosomes and Gene Expression
- Genetics and Genomics
- Research focus
- evolution
- gene/genome duplications
- cellular and molecular neuroscience
- G protein-coupled receptors (GPCR)
- neuropeptides
- endocrine peptides
- phototransduction
- ligand-gated ion channels
- Experimental organism
- human
- zebrafish
-
Rauf Latif
Icahn School of Medicine at Mount Sinai, United States
- Expertise
- Cell Biology
- Medicine
- Stem Cells and Regenerative Medicine
- Research focus
- metabolic syndrome
- thyroid
- GPCRs
- glycoprotein hormone receptors
- TSH receptor
- thyroid hormones
- receptor oligomerization
- post translational modification of receptors
- Experimental organism
- mouse
-
Sihoon Lee
Gachon University College of Medicine, South Korea
- Expertise
- Medicine
- Genetics and Genomics
- Research focus
- endocrinology
- hormones
- parathyroid
- bone metabolism
- rare diseases
- thyroid hormone metabolism
- deiodinase
- insulin resistance
-
Ellis Levin
University of California, Irvine, United States
- Expertise
- Medicine
- Research focus
- signal transduction in cells
- steroid receptors
-
Hongliang Li
Wuhan University School of Medicine, China
- Expertise
- Biochemistry and Chemical Biology
- Computational and Systems Biology
- Epidemiology and Global Health
- Immunology and Inflammation
- Medicine
- Research focus
- cardiometabolic disease
- metabolic disease
- vascular injury
- animal models
- liver
- innate immunity
-
Yi-Ping Li
Tulane University, United States
- Expertise
- Medicine
- Research focus
- orthopaedics
- surgery
- remodeling
- dental/craniofacial defects
-
Paloma B Liton
Duke University School of Medicine, United States
- Expertise
- Medicine
- Cell Biology
- Research focus
- ophthalmology
- glaucoma
- trabecular meshwork
- autophagy
- mechanical stretch
- lysosomes
- senescence
- lysosomal enzymes
- fibrosis
-
Huiping Liu
Northwestern University, United States
- Expertise
- Medicine
- Cancer Biology
- Research focus
- cancer stem cells
- circulating tumor cells
- exosome
- cancer immunity
- metastasis
- breast cancer
-
Nianjun Liu
Indiana University Bloomington, United States
- Expertise
- Medicine
- Research focus
- biostatistics
- applied statistics
- computational methods
- human health and diseases
-
Peng Liu
Icahn School of Medicine at Mount Sinai, United States
- Expertise
- Medicine
- Cell Biology
- Research focus
- obesity
- aging
- osteoporosis
- Adipose Biology
- Bone Biology (osteoblasts and osteoclasts)
-
Xiaorong Liu
University of Virginia, United States
- Expertise
- Neuroscience
- Medicine
- Research focus
- retina
- retinal ganglion cell
- retinal degeneration
- glaucoma
- in vivo imaging
- optic nerve
- axon bundles
- Experimental organism
- mouse
- tree shrew
-
Daria Lizneva
Icahn School of Medicine at Mount Sinai, United States
- Expertise
- Medicine
- Research focus
- endocrinology
- polycystic ovary syndrome (PCOS)
-
Francesc Lopez-Giraldez
Yale University, United States
- Expertise
- Medicine
- Research focus
- bioinformatics
-
Helen H Lu
Columbia University, United States
- Expertise
- Medicine
- Stem Cells and Regenerative Medicine
- Research focus
- bioengineering
- biomechanics
- orthopaedics
- tissue engineering
-
Andrew MacPherson
University of Bern, Switzerland
- Expertise
- Immunology and Inflammation
- Medicine
- Research focus
- mucosal immunity
- function of IgA
- mechanisms of host-microbial mutualism
-
Elham Mahmoudi
University of Michigan, United States
- Expertise
- Medicine
- Epidemiology and Global Health
- Research focus
- health services research
- large data analysis
- econometrics and methodology
- economics of dementia
- economics of aging
- disability
- healthcare cost and utilization
- disparity in health and healthcare
-
Arduino A Mangoni
Flinders Medical Centre, Australia
- Expertise
- Medicine
- Research focus
- pharmacology
- drug safety
- metabolomics
- biomarkers
- drug discovery
- hypertension
-
Arya Mani
Yale University School of Medicine, United States
- Expertise
- Medicine
- Genetics and Genomics
- Research focus
- lipid metabolism
- glucose metabolism
- fatty liver disease
- hyperlipidemia
- cardiovascular genetics
- Experimental organism
- mouse
-
Gherardo Mazziotti
Humanitas University of Milan, Italy
- Expertise
- Medicine
- Research focus
- endocrinology
- pituitary disease
- growth hormone
- thyroid
- FSH
- thyroid diseases
- secondary osteoporosis
- insulin-like growth factor-1
- ACTH
- cortisol
- prolactin
- TSH
- PTH
-
Gillian J McLellan
University of Wisconsin-Madison, United States
- Expertise
- Medicine
- Cell Biology
- Neuroscience
- Chromosomes and Gene Expression
- Research focus
- ophthalmology
- pathology
- imaging
- glaucoma
- retina
- optic nerve
- animal models
-
Rui Medeiros
Instituto Português de Oncologia-Porto, Portugal
- Expertise
- Medicine
- Cancer Biology
- Research focus
- oncology
- molecular oncology
- viral pathology
-
Simón Méndez-Ferrer
University of Cambridge, United Kingdom
- Expertise
- Stem Cells and Regenerative Medicine
- Developmental Biology
- Cancer Biology
- Medicine
- Research focus
- haematopoietic stem cell niche
- mesenchymal stem cells
- myeloproliferative neoplasms
- acute myeloid leukemia
- neuroimmunology
-
Pramod Mistry
Yale School of Medicine, United States
- Expertise
- Medicine
- Research focus
- gaucher disease
- lysosomal diseases
- genomics of liver disease
- metabolic liver diseases
- sphingolipids and inflammation
-
Subburaman Mohan
Loma Linda University, United States
- Expertise
- Medicine
- Genetics and Genomics
- Research focus
- bone biology
- endochondral bone formation
- insulin-like growth factors
- osteoporosis
- osteoarthritis
- skeletal development
- Experimental organism
- human
-
Zsolt Molnár
CytoSorbents Europe GmbH, Germany
University of Pécs, Hungary- Expertise
- Medicine
- Research focus
- sepsis
- septic shock
- hemodynamic monitoring
- fluid therapy
- extracorporeal cytokine removal
-
Tomohiro Morio
Tokyo Medical and Dental University, Japan
- Expertise
- Immunology and Inflammation
- Medicine
- Research focus
- primary immunodeficiency
- pediatrics
- cell therapy
- monogenic disorder
- iPS cells
-
Roberto Motterlini
INSERM U955, University Paris Est, France
- Expertise
- Medicine
- Research focus
- cardiovascular disease
- metabolism
- pharmacology
- inflammation
- oxidative stress
- heme oxygenase
- carbon monoxide
-
Nicola Napoli
Campus Bio-Medico University of Rome, Italy
- Expertise
- Medicine
- Research focus
- endocrinology
- metabolism
- osteoporosis
- bone fragility in diabetic reactions
- diabetes
- obesity
- clinical trials
- Experimental organism
- human
-
Anjaparavanda P Naren
Cedars-Sinai Medical Center, United States
- Expertise
- Medicine
- Cell Biology
- Research focus
- cystic fibrosis
- personalized medicine
- protein trafficking
- protein-protein interactions
- macromolecular complexes
- CFTR biology
-
Goutham Narla
University of Michigan, United States
- Expertise
- Medicine
- Cancer Biology
- Genetics and Genomics
- Research focus
- cancer therapeutics
- cancer genetics
- small molecule drug development
- protein phosphatase
- Experimental organism
- human
- mouse
-
Belinda Nicolau
McGill University, Canada
- Expertise
- Epidemiology and Global Health
- Medicine
- Research focus
- cancer epidemiology
- social determinants of health
-
Ole Haagen Nielsen
Herlev Hospital, University of Copenhagen, Denmark
- Expertise
- Medicine
- Research focus
- gastroenterology (especially inflammatory bowel disease)
- internal medicine
-
Jeremie Nsengimana
Newcastle University, United Kingdom
- Expertise
- Medicine
- Research focus
- statistics
- genomics
- cancer
- precision medicine
- biomarkers
-
Renata Pasqualini
Rutgers University, United States
- Expertise
- Medicine
- Cancer Biology
- Research focus
- radiation oncology
- translational cancer research
- prostate cancer
- vascular biology
-
David J Paterson
University of Oxford, United Kingdom
- Expertise
- Medicine
- Neuroscience
- Research focus
- autonomic neuroscience
- physiology
- cardiac arrhythmias
- hypertension
- chemoreception
- gene therapy
-
Julian Paton
University of Auckland, New Zealand
- Expertise
- Medicine
- Neuroscience
- Research focus
- autonomic neuroscience
- translational physiology
-
Luca Pinello
Massachusetts General Hospital, United States
- Expertise
- Medicine
- Computational and Systems Biology
- Genetics and Genomics
- Research focus
- bioinformatics
- computational biology
- CRISPR genome editing
- single-cell genomics
-
Nelly Pitteloud
CHUV, Switzerland
- Expertise
- Medicine
- Research focus
- human genetics
- metabolic disorders
- insulin resistance
- diabetes
-
Samuel Pleasure
University of California, San Francisco, United States
- Expertise
- Medicine
- Developmental Biology
- Neuroscience
- Research focus
- circuit development
- hippocampus
- cerebral cortex
- epilepsy
- human
- forebrain development
- autoimmune encephalitis
- morphogenic signals
- mouse
- multiple sclerosis
-
Markus Ploner
Technische Universität München, Germany
- Expertise
- Neuroscience
- Medicine
- Research focus
- pain
- brain
- oscillations
- synchrony
- electroencephalography (EEG)
- Experimental organism
- human
-
Serge Przedborski
Columbia University Medical Center, United States
- Expertise
- Neuroscience
- Medicine
- Research focus
- Parkinson's disease
- neurodegeneration
- mitochondrial damage
- motor neuron disease
- amyotrophic lateral sclerosis
- astrocytes
- autophagy
- mitophagy
- necroptosis
- apoptosis
- Experimental organism
- human
-
Matthew A Quinn
Wake Forest School of Medicine, United States
- Expertise
- Medicine
- Research focus
- translational liver disease
- obesity
- women's health
- fatty liver
- nuclear receptors
- reproduction
- epigenesis
-
Peter Ratcliffe
University of Oxford, United Kingdom
- Expertise
- Cell Biology
- Medicine
- Research focus
- hypoxia
- signaling
- hypoxia inducible factor
- prolyl hydroxylase
- oxygenase
- cysteine dioxygenase
- von Hippel-Landau
- N-degron
-
Michaela Reagan
Maine Medical Center Research Institute, United States
- Expertise
- Medicine
- Cancer Biology
- Cell Biology
- Stem Cells and Regenerative Medicine
- Research focus
- multiple myeloma
- bone marrow adipocyte
- fatty acid binding protein
- cancer-induced bone disease
- osteolysis
- Experimental organism
- mouse
-
Jalees Rehman
University of Illinois at Chicago, United States
- Expertise
- Cell Biology
- Genetics and Genomics
- Immunology and Inflammation
- Medicine
- Stem Cells and Regenerative Medicine
- Research focus
- vascular biology
- macrophage biology
- inflammation
- transcriptomics
- single cell analysis
- lung biology
- cell regeneration
-
Martin Reincke
Ludwig-Maximilians-Universität München, Germany
- Expertise
- Medicine
- Research focus
- endocrinology
- metabolism
- endocrine hypertension
- adrenal gland function
- pituitary-adrenal-axis
- pituitary disease
- cortisol, stress research
- adrenomedullary function
-
Albert Rizvanov
Kazan Federal University, Russia
- Expertise
- Medicine
- Research focus
- stem cells
-
Isabel Rodriguez-Barraquer
University of California, San Francisco, United States
- Expertise
- Epidemiology and Global Health
- Microbiology and Infectious Disease
- Medicine
- Research focus
- dengue
- malaria
- Zika
- vector-borne diseases
- serology
- modeling
- Experimental organism
- human
-
Antony Rosen
Johns Hopkins University School of Medicine, United States
- Expertise
- Medicine
- Research focus
- autoimmunity
- autoimmune disease
- rheumatic
- autoantibodies
- granzyme
-
Gian Paolo Rossi
University of Padua, Italy
- Expertise
- Medicine
- Research focus
- arterial hypertension
- vascular biology
- cardiology
- cardiovascular medicine
- endocrinology
- Experimental organism
- human
-
Maroeska M Rovers
Radboud University Nijmegen, Netherlands
- Expertise
- Medicine
- Research focus
- evidence-based surgery
- clinical epidemiology
- health economics
- IPD meta-analysis
-
Mishaela R Rubin
Columbia University Medical Center, United States
- Expertise
- Medicine
- Research focus
- diabetes
- parathyroid
- osteoporosis
-
Natalia Rubinstein
University of Buenos Aires-CONICET, Argentina
- Expertise
- Cancer Biology
- Immunology and Inflammation
- Medicine
- Stem Cells and Regenerative Medicine
- Research focus
- breast cancer tumor cell
- molecular biology
- drug resistance
- tumor immunology
-
Juan C Sáez
Universidad de Valparaíso, Chile
- Expertise
- Neuroscience
- Cell Biology
- Medicine
- Research focus
- connexin
- pannexin
- innexin
- neuroinflammation
- neuromuscular diseases
-
Fayez Safadi
Northeast Ohio Medical University, United States
- Expertise
- Medicine
- Stem Cells and Regenerative Medicine
- Research focus
- biomechanics
-
Tamer I Sallam
University of California, Los Angeles, United States
- Expertise
- Medicine
- Genetics and Genomics
- Research focus
- atherosclerosis
- lipid metabolism
- cardiovascular disease
- noncoding RNA
- gene regulation
-
Alan R Saltiel
University of California, San Diego, United States
- Expertise
- Medicine
- Immunology and Inflammation
- Cell Biology
- Research focus
- insulin
- action
- protein phosphorylation
- obesity
- metabolism
- diabetes
- signaling
- G proteins
-
Rebecca M Sappington
Wake Forest School of Medicine, United States
- Expertise
- Medicine
- Neuroscience
- Immunology and Inflammation
- Developmental Biology
- Research focus
- retina
- optic nerve
- neurodegeneration
- glia
- neuroinflammation
- regeneration
- axon
- cytokine/chemokine
-
Charles Sawyers
Memorial Sloan-Kettering Cancer Center, United States
- Expertise
- Cancer Biology
- Medicine
- Research focus
- translational medicine
- oncology
- Experimental organism
- human
-
Joshua T Schiffer
Fred Hutchinson Cancer Research Center, United States
- Expertise
- Microbiology and Infectious Disease
- Epidemiology and Global Health
- Immunology and Inflammation
- Medicine
- Research focus
- mathematical modelling
- herpesviruses
- HIV
- COVID-19
- T cell immunology
- Experimental organism
- human
- viruses
- HSV
- SARS-CoV-2
-
Nicolas Schlecht
Roswell Park Comprehensive Cancer Center, United States
- Expertise
- Epidemiology and Global Health
- Medicine
- Research focus
- cancer prevention
- cancer control
-
Nima Sharifi
Cleveland Clinic, United States
- Expertise
- Biochemistry and Chemical Biology
- Cancer Biology
- Medicine
- Research focus
- steroid biochemistry
- steroid metabolism
- prostate cancer
- nuclear receptors
- hormone therapy resistance
- androgens
- oncology
- Experimental organism
- mouse
-
Kalyanam Shivkumar
UCLA Health, United States
- Expertise
- Medicine
- Research focus
- electrophysiology
- neurocardiology
- cardiology
- neural control
- sudden death
- Experimental organism
- human
- mouse
-
Dolores Shoback
University of California, San Francisco, United States
- Expertise
- Medicine
- Research focus
- endocrinology
- hormones
- bone metabolism
- calcium
- mineral
- parathyroid
- vitamin D
- Experimental organism
- human
- mouse
-
Jawed Siddiqui
University of Nebraska Medical Center, United States
- Expertise
- Medicine
- Cancer Biology
- Research focus
- bone metastasis
- cancer metastasis
- chemokines
- osteoclasts
- osteoblasts
- tumor dormancy
- therapeutic
-
Viviana Simon
The Icahn School of Medicine at Mount Sinai, United States
- Expertise
- Epidemiology and Global Health
- Microbiology and Infectious Disease
- Medicine
- Research focus
- viral-host interactions
- retroviral restriction factors
- HIV drug resistance
-
Kellie N Smith
Johns Hopkins University School of Medicine, United States
- Expertise
- Medicine
- Immunology and Inflammation
- Research focus
- cancer immunology
- T cells
- immunogenomics
- T cell receptors
- neoantigens
- lung cancer
-
Kumaravel Somasundaram
Indian Institute of Science Bangalore, India
- Expertise
- Cell Biology
- Medicine
- Cancer Biology
- Genetics and Genomics
- Chromosomes and Gene Expression
- Research focus
- cell signalling
- glioma
- gene regulation
- cancer therapeutics
- cancer genomics
- cancer stem cells
- non-coding RNA
- chemoresistance
-
Renan P Souza
Universidade Federal de Minas Gerais, Brazil
- Expertise
- Genetics and Genomics
- Medicine
- Research focus
- molecular epidemiology
- genomics
- biomarkers
- statistical modeling
- cohort studies
- case-control studies
- simulation studies
-
Pramod K Srivastava
UConn Health, United States
- Expertise
- Medicine
- Immunology and Inflammation
- Research focus
- cancer immunology
- tumor antigens
- neoantigens
- cancer vaccines
- immunotherapy
- antigen presentation
- neoepitopes
- cross-presentation
- Experimental organism
- mouse
- human
-
Jonathan S Stamler
Case Western Reserve University, United States
- Expertise
- Medicine
- Biochemistry and Chemical Biology
- Research focus
- S-nitrosylation
- nitric oxide
- redox
- redox-signaling
- cysteine
- thiols
-
Margaret Stanley
University of Cambridge, United Kingdom
- Expertise
- Cancer Biology
- Microbiology and Infectious Disease
- Medicine
- Epidemiology and Global Health
- Research focus
- vaccines
- cervix cancer
- cervix precancer
- keratinocyte biology
- human papillomavirus
- DNA viruses
- vaccine immunology
- Experimental organism
- human
-
Larisa Suturina
Scientific Center for Family Health and Human Reproduction, Russia
- Expertise
- Medicine
- Research focus
- women's health
- infertility
- polycystic ovary syndrome (PCOS)
- oxidative stress
- menopause
- obesity
- hypothalamic disorders
- antioxidants
- contraception
- POF
- adolescent's health
-
Kiyoshi Takeda
Osaka University, Japan
- Expertise
- Immunology and Inflammation
- Medicine
- Research focus
- mucosal immunology
- inflammatory bowel disease
- intestinal immunity
- intestinal environmental factors
- intestinal epithelial cells
-
Sakae Tanaka
The University of Tokyo, Japan
- Expertise
- Medicine
- Research focus
- bone
- osteoporosis
- osteoclast
- osteoarthritis
- rheumatoid arthritis
- orthopaedics
-
Rudolph E Tanzi
Harvard University, United States
- Expertise
- Neuroscience
- Genetics and Genomics
- Medicine
- Research focus
- Alzheimer's disease
- genetics
- neurodegenerative disease
- amyloid
- neuroinflammation
- Experimental organism
- mouse
- human
- brain organoids
-
Mauro M Teixeira
Universidade Federal de Minas Gerais, Brazil
- Expertise
- Medicine
- Immunology and Inflammation
- Microbiology and Infectious Disease
- Research focus
- inflammation
- mediators of inflammation
- pharmacology
- anti-viral compounds
- arboviral infections
- clinical trials
-
Carmen D Tekwe
Indiana University Bloomington, United States
- Expertise
- Medicine
- Research focus
- biostatistics
- dietary intake
- physical activity behavior
-
Aseem Prakash Tikku
King George's Medical University, India
- Expertise
- Medicine
- Research focus
- dentistry
- endodontics
-
Peter Tontonoz
University of California, Los Angeles, United States
- Expertise
- Cell Biology
- Medicine
- Research focus
- lipid metabolism
- cholesterol
- nuclear receptors
- adipocytes
- obesity
- atherosclerosis
- diabetes
- Experimental organism
- mouse
-
Ritu Trivedi
CSIR-Central Drug Research Institute, India
- Expertise
- Medicine
- Research focus
- drug development
- animal models of endocrine diseases
-
Farah Usmani
United Nations Population Fund (UNFPA), United States
- Expertise
- Medicine
- Research focus
- health policy
- reproductive health
- reproductive rights
-
Frank van de Veerdonk
Radboud University Medical Center, Netherlands
- Expertise
- Immunology and Inflammation
- Microbiology and Infectious Disease
- Medicine
- Research focus
- medical mycology
- clinical immunology
-
Amit Verma
Albert Einstein College of Medicine, United States
- Expertise
- Medicine
- Cancer Biology
- Research focus
- leukemia
- cancer stem cells
- myelodysplasia
- clonal hematopoiesis
-
Mei Wan
Johns Hopkins University School of Medicine, United States
- Expertise
- Medicine
- Cell Biology
- Research focus
- bone remodeling
- osteoarthritis
- osteoblasts
- osteoclast
- cellular senescence
- mesenchymal stem cells
- progenitor cells
-
Linghua Wang
The University of Texas MD Anderson Cancer Center, United States
- Expertise
- Cancer Biology
- Computational and Systems Biology
- Genetics and Genomics
- Immunology and Inflammation
- Medicine
- Research focus
- computational biology
- cancer immunogenomics
- cancer genomics
-
Tracey L Weissgerber
Berlin Institute of Health (BIH) at Charité, Germany
- Expertise
- Medicine
- Research focus
- data visualization
- statistical analysis
- reproducibility
- meta-research
- open and reproducible methods
- systematic review
- scientific rigor
- transparency
- automated screening
-
Christopher S Williams
Vanderbilt University, United States
- Expertise
- Medicine
- Research focus
- gastroenterology
- GI track cancer
- murine
- inflammatory bowel disease
-
Wei Yan
University of California, Los Angeles, United States
- Expertise
- Developmental Biology
- Genetics and Genomics
- Medicine
- Research focus
- fertility
- germ cells
- reproduction
- epigenetic inheritance
- epigenomics
- noncoding RNAs
- post-transcriptional regulation
-
Qifeng Yang
Qilu Hospital of Shandong University, China
- Expertise
- Medicine
- Cancer Biology
- Research focus
- breast cancer
- cancer stem cells
- metastasis
- cancer associated fibroblasts
- chemoresistance
-
Yongliang Yang
Dalian University of Technology, China
- Expertise
- Medicine
- Cancer Biology
- Computational and Systems Biology
- Research focus
- bioinformatics
- computational biology
- drug discovery
- artificial intelligence
-
Yunlei Yang
Albert Einstein College of Medicine, United States
- Expertise
- Medicine
- Neuroscience
- Research focus
- glia
- neural circuits
- anxiety
- diabetes
- obesity
- neuron
-
Keqiang Ye
Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, China
- Expertise
- Medicine
- Cancer Biology
- Biochemistry and Chemical Biology
- Neuroscience
- Research focus
- neuroscience
- molecular cytobiology
- cancer biology
- neurodegenerative disease
- Experimental organism
- mouse
-
Tony Yuen
Icahn School of Medicine at Mount Sinai, United States
- Expertise
- Medicine
- Research focus
- genetics of rare diseases
- prenatal diagnosis
-
Mark L Zeidel
Beth Israel Deaconess Medical Center, United States
- Expertise
- Medicine
- Research focus
- kidney disease
- bladder disease
-
Baohong Zhao
Hospital for Special Surgery, United States
- Expertise
- Medicine
- Cell Biology
- Research focus
- osteoclast
- osteoimmunology
- bone
- TNF
- Experimental organism
- mouse
-
Siming Zhao
Dartmouth College, United States
- Expertise
- Medicine
- Computational and Systems Biology
- Genetics and Genomics
- Research focus
- statistical genetics
- genomics
- human genetics
- sequencing data
-
Shengtao Zhou
Sichuan University West China Second University Hospital, China
- Expertise
- Cancer Biology
- Medicine
- Research focus
- gynecologic oncology
- cancer biology
- tumor immunology
- metabolism
- nuclear receptors
- systems biology
- Experimental organism
- human
- mouse
-
Hao Zhu
University of Texas Southwestern Medical Center, United States
- Expertise
- Cancer Biology
- Stem Cells and Regenerative Medicine
- Medicine
- Research focus
- mechanisms of tissue repair and organ regeneration
- liver cancer
- hepatocellular carcinoma
- epigenetics
- polyploidy
- Experimental organism
- human
- mouse
-
Bian Zhuan
Wuhan University, China
- Expertise
- Medicine
- Genetics and Genomics
- Research focus
- craniofacial genetics
- oral and craniofacial developmental defects
- orofacial clefts
- tooth agenesis
-
Roger S Zoh
Indiana University Bloomington, United States
- Expertise
- Medicine
- Research focus
- Bayesian statistical methods